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Abstract
The effects of a stress management program upon the Type A behavior 
pattern were examined in a sample of patients with coronary heart 
disease who were enrolled in an on-going cardiac rehabilitation program. 
Based upon exhibition of Type A behavior (defined by the Structured 
Interview), patients were randomly assigned to three experimental 
conditions: (a) behavioral stress management, (b) supportive (attention 
placebo control group), and (c) no treatment (waiting list control 
group). Patients receiving treatment attended 10 sessions of 1-1% hours 
duration, as well pretreatment and posttreatment assessment sessions. 
Patients in the no treatment condition also completed the assessments.
The evaluation of treatment outcome was based upon pre- to 
post-treatment change. Hypotheses that patients in the behavioral 
stress management condition would demonstrate greater reductions than 
the supportive and no treatment conditions on measures of the behavior 
pattern and cardiovascular reactivity during the Quiz Electrocardiogram 
(QE) and cold pressor were not supported. Changes during treatment 
were, however, significant for some of the Type A measures (Structured 
Interview, Framingham Scale, and Bortner Scale) and the QE but did not 
distinguish between experimental conditions. Cold pressor results 
demonstrated neither a significant time (pre- to post-treatment) by 
group (experimental conditions) interaction nor a significant time 
effect. Secondary variables (lipids, anxiety, and marital satisfaction) 
demonstrated a similar pattern of results. Results did offer a slight 
suggestion that the assessment procedures may have had a sensitizing 
effect which motivated patients to act more appropriately with respect
vii
to the stressors in their lives and that participation in treatment may 
have assisted patients' daily coping with stress.
As a whole, this intervention program was not effective. The lack 
of positive outcome is discussed in terms of possible mitigating 
factors, i.e., a negative association between Type A behavior and 
severity of coronary artery disease, patients' ages, patients' 
medication, and patients' prolonged participation in an exercise 
oriented rehabilitation program. The present results suggest that 
specific Type A interventions are not necessary for all coronary 
patients and that the parameters of matching coronary patients with 
psychological interventions need refinement.
viii
INTRODUCTION
Coronary heart disease (CHD) * has been and continues to be the 
leading cause of death in the United States (Krantz, Glass, Schaeffer, & 
Davia, 1982; World Health Organization, 1970). The social and economic 
costs are staggering. Annual mortality estimates range from 600,000 due 
to CHD (Fishman, 1982) to 1,000,000 due to heart and blood vessel 
disease (Russell, 1980). As far back as 1963, Felton and Cole estimated 
that the economic loss from CHD was over four billion dollars annually, 
excluding financial losses due to early death. Further, approximately 
28 million people with cardiovascular disease require continuous medical 
care or rehabilitation, which has attendant social and financial costs. 
Considering the magnitude of this problem, research has focused upon 
identifying factors associated with CHD, e.g., the Framingham Heart 
Disease Epidemiology Study (Kannel, McGee, & Gordon, 1976) and the 
Western Collaborative Group Study (Rosenman et al., 1964; Rosenman, 
Brand, Sholtz, & Friedman, 1976). These and other investigations have 
led to the identification of CHD risk factors such as sex, age, elevated 
levels of low-density lipoproteins, cholesterol, and triglycerides, low 
levels of high-density lipoproteins, diabetes mellitus, hypertension, 
obesity, smoking, lack of exercise, and a familial history of heart 
disease (Krantz et al., 1982, Suinn, 1982). However, because reliance
1 The terms coronary heart disease (CHD) and coronary artery disease 
(CAD) are distinguishable, i.e., heart versus arterial disease, but 
are frequently used interchangeably. CHD is the more inclusive term 
and the term more frequently used in the literature. This paper will, 
therefore, use the term CHD unless the respective author makes the 
distinction or the discussion is focused upon arterial disease.
1
2these factors predicts less than half the incidence of new heart attacks 
(Jenkins, 1971; Keys et al.,1972), additional risk factors have been 
sought.
Chief among the potential risk factors that have been examined are 
psychosocial stress and certain behavior patterns (Krantz et al., 1982). 
Of the two factors, the behavior pattern, Type A (Friedman & Rosenman, 
1959) has received the most consistent support (Friedman et al., 1982; 
Newlin, 1981). A recent report by Blumenthal (1982) summarizes the 
contributions of various risk factors to CHD (see Table 1). While the 
risk factors in Table 1 have been significantly correlated with CHD, 
their respective contributions are sometimes confounded by associations 
with other risk factors, e.g., obesity with cholesterol and an inactive 
lifestyle, or the particular substrate of a risk factor, may be in 
dispute, e.g., high-density lipoprotein cholesterol, low-density 
lipoprotein cholesterol, and very-low-density lipoprotein cholesterol 
(Abbott, Garrison, Wilson, & Castelli, 1982). Finally, the hypothesis 
has been offered that all of the risk factors may be secondary to the 
Type A behavior pattern (TABP) (Friedman, 1979; Friedman et al., 1982). 
As implied, the evidence for psychosocial stress and , in particular, 
psychological stress, is not as consistent as the evidence for TABP 
(Krantz et al., 1982). However, of particular relevance to the present 
proposal is the implication of acutely stressful life events beyond the 
individual's control in coronary disease (Glass, 1977; Jenkins, 1971; 
1976). In addition, there seems to be an association between the TABP 
and stress, i.e., the appearance, or elicitation of the Type A pattern
3Cardiovascular Risk Profile
Table 1
Characteristic Risk Profile Risk
Age (years) >65 ++
45-65 +
<45 - ■
Sex Male ++
Female -
Family History MI <55 +++
MI <65 +
CVD <65 +
absent -
Cholesterol level (mg %) §270 +++
240-269 ++
221-239 +
^220 -
Triglyceride level (mg %) £200 ++
151-199 +
S150 -
Blood pressure (mm Hg) >160 (systolic) and/or
>100 (diastolic) 
140-159 (systolic) and/or
+++
90-99 (diastolic) 
100-139 (systolic) and/or
+++
69-89 (diastolic) —
Smoking >one pack per day +++
<one pack per day ++
Stopped at least 5 years +
Nonsmoker —
Behavior patterns Type A (symptomatic) +++
Type A (asymptomatic) +
Type B (asymptomatic) —
Exercise None or some irregular +
regular aerobic exercise —
Obesity Severe ++
Moderate +
Mild —
+++ = severe: ++ = moderate: + mild: - not significant.
from Blumenthal (1982)
4under stressful conditions (Glass, 1977). A discussion of these three 
topics, psychological stress, the Type A behavior pattern (TABP), and 
their interaction, follows.
Psychosocial stress and coronary heart disease
Psychosocial stress has been implicated as an etiological factor in 
physical disorders, e.g., cancer (Sklar & Anisman, 1981) and 
musculoskeletal disorders (Stovya, 1979), and psychiatric disorders 
(American Psychiatric Association, 1980). Coronary heart disease is not 
an exception to this conclusion and reviews have concluded that a 
relationship does exist between stress and CHD. In a recent paper,
Razin (1982) concluded that "there are positive associations of some 
kind between psychosocial factors and CAD development" (p. 363). As 
might be expected, different psychosocial factors show different degrees 
of association. The influence of stress appears to be due to the 
adaptation required to cope with the stressor. Further, the stress is 
considered to exert a strain upon the individual which may eventually 
result in organ damage (Blumenthal, 1982). While a thorough review of 
psychological factors is beyond the scope of this paper, pertinent 
research will be briefly reviewed. For a more extensive summary, the 
interested reader is referred to reviews by Glass (1977) and Jenkins 
(1971; 1976).
For the most part, the examination of the relationship between 
psychosocial stress and CHD has not proven fruitful except in fairly 
well delineated areas. Many of the earlier studies examined various 
demographic variables and, in general, the relationships have not been 
consistent (Jenkins, 1976; Razin, 1982). A notable exception is the
5consistent data concerning national mortality rates. Keys (1970) 
obtained marked differences in CHD incidence, prevalence, and mortality 
according to nationality. The seven country survey reported rates of 
angina, infarction, and death to be three to four times higher in 
Finland and the United States than in Japan, Greece, and Yugoslavia 
(Keys, 1970). Clearly though, international comparisons are confounded 
by genetic and cultural factors. Similarly, reports which have examined 
socioeconomic factors have obtained positive associations but are 
frequently flawed by inattention to covarying factors, e.g., financial 
and occupational promotions usually occur with advancing age which also 
raises the risk of CHD. In general, results indicate that major 
changes/differences in residence, occupation, status, mobility, and 
cultural congruity may affect the rate of CHD. However, the unifying 
theme of changing CHD rates seems to be that as individuals move into 
unfamiliar social circumstances or environments for which they have not 
been prepared, CHD rates increase (Russek & Russek, 1976).
Another area of investigation has been neuroticism and, in 
particular, anxiety and depression. Several reports have demonstrated 
differences on the MMPI between patients with coronary disease and 
healthy individuals (e.g., Bakker & Levenson, 1967; Bruhn, Chandler, & 
Wolf, 1969; Lebovits, Shekelle, Ostfeld, & Paul, 1967; Ostfeld,
Lebovits, Shekelle, & Paul, 1964). The most prominent differences have 
been on the "neurotic triad," Hs, D, and Hy. Scale means for angina 
patients were higher than normals and myocardial infarction (MI) 
patients were lower than normals. An association between anginal pain 
and hypochondriasis (MMPI) has also been reported by Jenkins (1971). 
Studies using the 16PF have yielded similar results. Bakker (Bakker,
61967; Bakker & Levenson, 1967) and others have reported increased 
emotional instability in angina patients compared with MI patients while 
all of the Coronary disease patients exhibited some emotional problems 
(Jenkins, 1971; 1976). The experimental evidence, thus, suggests that 
"neurotic" problems are associated with coronary disease and that, in 
particular, neuroticism may be linked with morbidity while anxiety 
and/or depression may be linked with angina (Jenkins, 1976; Razin,
1982). While the preceding studies have been both prospective and 
retrospective and, thereby, suggestive of coronary risk, results could 
possibly indicate a subclinical disease process (Friedman, Ury, Klatsky, 
& Siegelaub, 1974). Consequently, the predictive significance of 
psychological distress remains an investigative question.
Another area of psychosocial stress which has generated 
experimental investigation is life changes. Much of this work was 
prompted by Holmes and Rahe and their examinations of the concomitants 
of life changes, both positive and negative (e.g., Holmes & Rahe, 1967). 
A number of retrospective studies have demonstrated an increase in life 
changes during the six months preceding symptom onset in MI patients 
(Theorell & Rahe, 1971; Jenkins, 1976). Further, patients perceive 
stressful events as a major cause of their illness. Blumenthal (1982) 
reported that 59% of 44 consecutive MI patients viewed stress as 
significant in their condition. The difficulty with most of these 
studies is the lack of an adequate control group (Jenkins, 1976). That 
is, patients serve as their own controls in recalling events in the last 
six months, as well as, earlier time periods. Thus, life change may be 
a function of better recent memory than distant memory. The MI may also 
serve as a sensitizing event with patients searching for reasons for
7their MI.
In prospective studies of life change and coronary events, the 
evidence is mixed. For example, Parkes, Benjamin, and Fitzgerald (1969) 
followed over 4,000 widowers for nine years after the death of their 
wives. The mortality due to CHD was 67% above the expected rate for 
married men of the same age. Opposing results were reported by 
Theorell, Lind, and Floderus (1975) who followed 6,500 construction 
workers for 12 to 15 months. Elevated life change scores and MI 
incidence showed no relationship. In sum, the evidence is promising but 
mixed. Based upon his review of the literature, Razin (1982) concluded 
that stressful life events seem linked to general morbidity rather than 
coronary morbidity. This conclusion echoes Jenkins (1971; 1976) who 
stated that the evidence is provocative but unconvincing due to 
inconsistencies between studies.
The preceding review, albeit brief, suggests that psychosocial 
factors may very well play a role, or serve as risk factors in the 
genesis of CHD. However, the complexity of factors and the difficulty 
in separating respective influences has made research difficult. 
Consequently, a definitive understanding of psychosocial influences is 
not yet possible (Razin, 1982). Indeed, all of the preceding factors 
are broadly conceptualized as stressors, e.g., growing up in Western 
society, being anxious, or having a spouse die. The evidence seems 
clear that some individuals who experience these stressors do develop 
heart disease. However, we all experience stress but we do not all 
develop heart disease. The question would, then, seem to be are some 
individuals prone to developing CHD in response to stress. The Type A
8behavior pattern is the variable, or construct, which has been proposed
as mediating the association between stress and CHD.
Type A behavior pattern and coronary heart disease
While the TABP was first hypothesized as an etiological factor in
the genesis of CHD by Friedman and Rosenman in 1959, they were not the
first to recognize the association between behavior and the heart as the
following quotations illustrate.
A mental disturbance provoking pain, excessive joy, hope 
or anxiety extends to the heart, where it affects its 
temper, and rate, impairing general nutrition and vigor.
It is no wonder many serious diseases thus gain access to 
the body, when it is suffering from faulty nourishment 
and lack of normal warmth.
William Harvey (1628)
In the worry and strain of modern life, arterial 
degeneration is not only very common but develops often 
at a relatively early age. For this I believe that the 
high pressure at which men live and the habit of working 
the machine to its maximum capacity are responsible 
rather than excesses in eating and drinking.
William Osier (1897)
In a group of 20 men (with angina pectoris), every one of 
whom I knew personally, the outstanding feature was the 
incessant treadmill of practice; and yet if hard 
work— the badge of all of our tribe - was alone 
responsible, would there not be a great many more cases?
Every one of these men had an added factor - worry; in 
not a single case under 50 years of age was this feature 
absent.
William Osier (1920)
Friedman and Rosenman (1959) first defined the Type A individual as 
one who exhibits enhanced personality traits of aggressiveness, 
ambitiousness, competitive drive, is work oriented with preoccupation 
with deadlines, and exhibits impatience with a strong sense of time 
urgency. Since 1959, the definition has evolved as a result of
9continuing research into the development of the behavior pattern and the
pathogenesis of heart disease. Recently, Friedman, Thoresen, and Gill
(1981) defined the TABP as follows.
"Type A behavior pattern is an action-emotion complex 
characterized by a chronic and incessant struggle 
indulges in by persons who (1) attempt to achieve more 
and more in less and less time and (2) also frequently 
harbor a free-floating hostility that is often covert and 
usually well-rationalized. The sense of time urgency and 
hostility felt by these persons gives rise to the 
aggravation, irritation, anger, and impatience (AIAI) so 
often exhibited by them. Indeed, these latter emotional 
components form the core of Type A behavior." (p 81)
The behavior pattern is not considered a fixed personality trait which
is unalterable. Rather, the behavior pattern is considered to be a
learned behavior which is composed of well-established habit patterns.
The patterns are often acquired early in life through experience in the
home and the individual's cultural experiences (Friedman et al., 1981).
Note should be made that the Type A pattern is neither a stressor nor a
response but is, rather, a behavioral style which appears in some people
in response to challenging situations (Razin, 1982).
The original formulation of the TABP was based upon Friedman and 
Rosenman's work as cardiologists at the Harold Bruhn Institute at Mount 
Zion Hospital in San Francisco. Since 1959, the TABP has been 
repeatedly shown to be associated with CHD in 12 retrospective studies 
and seven small scale (relative to the Western Collaborative Group Study 
and the Framingham Heart Study) prospective studies (Jenkins, 1976). In 
the Western Collaborative Group Study (WCGS), Rosenman et al. (1964) 
assessed 3154 healthy (no indications of CHD) middle and upper income 
men on standard risk factors and the TABP. The men were between the 
ages of 39 and 59. At two year follow-up, 54 of 1584 Type A men had
10
developed clinical CHD versus 16 of the 1598 Type B men (Rosenman et 
al., 1966). The risk ratio for the development of CHD for Type A 
compared to Type B individuals was 3.4. By the 4% year follow-up, the 
risk ratio was 2.7 and the presence of the TABP was the single best 
predictor of CHD (Rosenman et al., 1970). At 8% year follow-up, the 
approximate relative risk was 1.9 for men aged 39 to 49 and 2.2 for men 
aged 50 to 59 (at entry) (Rosenman, Brand, Sholtz, & Friedman, 1976).
In the Framingham Heart Study similar results were obtained
(Haynes, Feinleib, & Kannel, 1980). Over the course of an eight year
period, men and women who had initially been free of CHD and classified 
as Type A were twice as likely to develop heart disease as men and women 
classified as Type B. The Framingham study involved 1674 coronary free 
individuals. Further, direct comparison and application of the 
Framingham predictive equation to WCGS subjects (Brand, Rosenman,
Sholtz, & Friedman, 1976) results in a comparable number (to the 
observed) of CHD events. Thus, the Brand et al. (1976) results
represent a cross validation of CHD predictive equations. Brand et al.
state that the removal of the risk associated with TABP would correspond 
to a 31% reduction in CHD incidence in the WCGS.
The association between the TABP and CHD is not solely based upon 
initial clinical endpoints, e.g., diagnosable MI or death, but has also 
been examined with respect to arteriographic results and recurrent MI. 
Several studies have examined the severity of coronary artherosclerosis 
with arteriography (cardiac catheterization) and documented a positive 
relationship with the TABP (Blumenthal, Williams, King, Schanberg, & 
Thompson, 1978; Frank, Heller, Kornfeld, Sporn, & Weiss, 1978; Krantz, 
Sanmarco, Selvester, & Matthews, 1979; Williams et al., 1980; Zyzanski,
11
Jenkins, Ryan, Flessas, & Everist, 1976). However, Dimsdale and his 
colleagues (Dimsdale, Hackett, Catanzano, & White, 1979a; Dimsdale, 
Hackett, Hutter, Black, & Catanzano, 1978; Dimsdale et al., 1979b; 
Dimsdale, Hutter, Hackett, & Block, 1981) and Kornitzer et al., (1982) 
failed to document a positive relationship. The reason(s) for these 
apparently contradictory results is unclear (Williams et al., 1980), but 
may relate to population differences (Dimsdale et al., 1979) or to the 
methods of assessment (Kornitzer et al., 1982). In discussing their 
results, Kornitzer et al. suggest that their use of the Bortner Scale to 
assess TABP (see the later discussion of TABP assessment), may account 
for their negative results. Further, in assessing CAD severity,
Dimsdale et al. (1978; 1979; 1981) used a weighting procedure which 
considers the amount of myocardium with impaired circulation. Studies 
obtaining a positive relationship be the TABP and disease severity have, 
most often, simply graded the four major coronary arteries on the degree 
of occlusion. In sum, five of the nine arteriographic reports support a 
positive relationship between the TABP and atherosclerosis and 
methodological differences may mitigate the conclusions of Dimsdale et 
al. (1978; 1979; 1981) and Kornitzer et al. (1982).
Three studies have examined the role of the TABP in recurrent 
myocardial infarction (Jenkins, Zyzanski, & Rosenman, 1976; Jenkins, 
Zyzanski, Rosenman, & Cleveland, 1971; Rosenman et al., 1967) and all 
reported a positive relationship. The Recurrent Coronary Prevention 
Project (Friedman et al., 1982; 1984; Powell, Friedman, Thoresen, Gill,
& Ulmer, 1984; Thoresen, Friedman, Gill, & Ulmer, 1982) has also 
demonstrated that reductions in TABP are associated with reductions in
12
coronary events. In the most recent report from this project, the 
recurrence rate in patients exhibiting significant reductions in Type A 
behavior was one fourth that of patients not exhibiting significant 
reductions, i.e., 1.7% vs 8.6% (Friedman et al., 1984). In addition, 
Jenkins et al. (1971) reported on a small sample, 17 patients, who died 
of CHD. The TABP was not significantly related to death but the authors 
noted that the meaning of their observations, a trend toward increased 
speed and impatience among the fatal cases, awaits a larger sample of 
fatal CHD cases. Similarly, Rosenman et al. (1967) reported a 
non-significant trend of increased incidence of the TABP among MI 
fatalities compared to survivors.
Despite these rather consistent and impressive results, the TABP is 
not a area of investigation without controversy. For example, the 
preceding discussion details the statistical significance of the 
association between the TABP and CHD while the clinical significance 
remains to be fully documented. Newlin (1981) points out that the best 
predictor of recurrent CHD events is a previous history of heart attack 
and that by itself the TABP results in a population in which less than 
half eventually develop CHD. While postponing intervention until a 
heart attack occurs is less than desirable from a prevention standpoint, 
the wisdom of expending massive resources on non-at-risk populations in 
an age of public accountability can be questioned. The problem is the 
degree to which Type A behavior is truly coronary-prone behavior.
In discussing or considering TABP intervention, the reader should 
be aware that the utility of risk factor intervention of any magnitude 
or in any CHD risk factor has been questioned (e.g., Corday & Corday,
13
1975). In addition, large scale risk factor interventions have resulted 
in either non-significant changes (Multiple Risk Factor Intervention 
Trial (MRFIT) Research Group, 1982), marginal changes (Stern, Farguhar, 
Maccoby, & Russell, 1976), or been open to question due to 
methodological inadequacies (Leventhal, Safer, Cleary, & Gutmann, 1980).
In an attempt to answer the preceding questions and resolve the 
controversy surrounding CHD and the TABP, the National Heart Lung and 
Blood Institute (NHLBI) recently sponsored the Review Panel on 
Coronary-prone Behavior and Coronary Heart Disease (1981). The Review 
Panel undertook "A comprehensive, impartial and objective review" (p 
1199) of the data and concluded that Type A behavior was associated with 
increased risk of clinical CHD. The risk was considered to be greater 
than the risk due to age, elevated systolic blood pressure and 
cholesterol, and smoking. In addition, the relative risk of the TABP is 
considered to be of the same magnitude as elevated systolic blood 
pressure and cholesterol, and smoking. Additional portions of the 
report detail unresolved questions and provide suggestions for 
continuing research. Of particular relevance to the present proposal 
are the following Review Panel conclusions: (1) patients with known CHD
should be given primary consideration for intervention trials, (2) the 
risks of such interventions are small and the benefits are potentially 
enormous, (3) the use of therapeutic interventions in Type A behavior 
remains a realm for investigation, (4) current information concerning 
short-term effectiveness is insufficient, (5) the goal of intervention 
should be a change in level (intensity) of the Type A pattern or a 
subset of its components, and (6) treatment groups need not be large 
(Review Panel, 1981).
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Stress and TABP interaction
As has been mentioned, stress and the TABP seem to be a 
particularly potent combination which has received considerable 
attention in the literature (e.g., Friedman & Rosenman, 1959; Glass, 
1978; Krantz et al., 1982). To summarize the experimental evidence,
Type A's (a) show heightened achievement strivings, (b) suppress or 
ignore subjective states like fatigue which either threaten or interfere 
with their best performance, (c) rapidly pace themselves, (d) become 
impatient with delays, (e) express hostility and aggression when 
frustrated in task completion, (f) perform poorly when slow responding 
is required, and (g) focus on central tasks while ignoring peripheral 
cues which might deter performance (Glass, 1978; Krantz et al., 1982). 
These behaviors are thought to represent an attempt to gain 
environmental control and, thereby, avoid the anxiety which stems from 
the threat of losing control and not being able to cope. The Type A 
individual is, thus, engaged in a perpetual struggle for control even 
under minimally stressful conditions. In comparison, the Type B 
individual is relatively free from this control struggle and, thereby, 
free of the Type A characteristics (Glass, 1978). Unfortunately, Type A 
individuals find themselves in no-win situations for as they master or 
cope with successive stressors (or challenges), society reinforces their 
success (e.g., promotions, financial reward, recognition, etc.) and new 
challenges present themselves.
The Type A's pattern of responding has been elaborated upon by 
Glass (1978) and is based upon his work with Type A's and uncontrollable 
stress. Initially, when confronted by a stressor, the Type A shows 
hyperresponsiveness, presumably, reflecting effort to assert control and
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master the situation. Even after experience with the stressor as 
uncontrollable, Type A's persevere and become even more motivated to 
assert control. However, after repeated failure, the uncontrollability 
is perceived and the Type A's become hyporesponsive. A similar pattern 
is shown by the Type B's but the Type B's are not as persistent in 
attempting to assert control and do not become as hyporesponsive when 
the stressor is perceived as uncontrollable. The Type A pattern of 
hyperresponsiveness followed by hyporesponsiveness is most pronounced 
under conditions of high stress rather than moderate stress. In other 
words, when the uncontrollability of stress is highly salient, e.g., 
loud noise, Type A's will initially respond rapidly, learn that the 
stress can not be controlled, and become hyporesponsive. Under moderate 
or low salience conditions, e.g., soft noise, Type A's exert less 
initial effort, less effectively learn the non-contingency, and fail to 
exhibit hyporesponsiveness. In addition, repeated exposure to salient, 
uncontrollable stress seems to result in enhanced susceptibility to 
hyporesponsiveness, or helplessness, and possible CHD (Glass, 1978).
Given these behavioral changes, the next logical step is the 
identification of the physiological mechanisms by which the TABP is 
translated into clinical CHD. While the definitive identification has 
yet to occur (Razin, 1982; Suinn, 1982), a reasonable hypothesis, which 
has considerable support, is that Type A behaviors are accompanied by 
physiological activity which facilitates the atherosclerotic process 
(Dembroski, MacDougall, Herd & Shields, 1979). While the bulk of the 
research has been conducted with healthy, young adults (Corse, Manuck, 
Cantwell, Giordani, & Matthews, 1982), there do appear to be some 
consistencies (Dembroski, 1981). Type A's, compared with Type B's,
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respond significantly more to a wide variety of challenges, e.g., 
reaction time tasks, TV video games, and the cold pressor, with 
elevations in systolic blood pressure and heart rate. Studies which 
have examined CHD populations (e.g., Corse et al., 1982; Dembroski et 
al., 1979; Sime, Buell, & Eliot, 1980) suggest that CHD may compound the 
Type A physiological responsivity.
A methodological note of importance is that when the behavior 
pattern has been assessed with the Jenkins Activity Survey (see 
following discussion of assessment), physiological relationships have 
frequently been absent. In comparison, use of the Structured Interview 
(see following discussion of assessment) has resulted in significant 
associations between the TABP and physiological reactivity (Corse et 
al., 1982; Dembroski, 1981). In addition, the attributes of the TABP 
which are most closely associated with CHD, i.e., the overt, behavioral 
stylistics, provide the best prediction of physiological reactivity. As 
previously discussed in summarizing Glass' (1978) work with 
uncontrollable stress (the A/B distinctions were most prominent under 
conditions of high stress), the Type A elevations in blood pressure and 
heart rate were most pronounced under high challenge conditions 
(Dembroski et al., 1979). In conclusion, it appears that the TABP is 
frequently associated with heightened physiological responses to 
environmental challenges. That the association is not invariant is not 
surprising for the association between the TABP and CHD is far from a 
perfect correlation (Dembroski, 1981).
While a physiological explanation of the foregoing phenomena is 
only speculative at present, the evidence suggests that the chronic 
overactivity of neuroendocrine, lipid metabolism, and physiological
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response systems may promote injury to the arterial endothelium (Ross & 
Glomset, 1976) which may be responsible for atherogenesis (Blumenthal & 
Williams, 1982). In particular, the sympathetic - adrenomedullary (SAM) 
system has been implicated as mediating stress, the TABP, and CHD 
(Krantz et al., 1982). The physiological consequences of increased SAM 
activity, i.e., increased blood pressure, heart rate, and myocardial 
oxygen consumption, elevated levels of epinephrine, norepinephrine, and 
free fatty acids, and increased plasma renin activity, all have the 
potential to predispose to cardiovascular diseases (Herd, 1978). Within 
this conceptualization, the catecholamines (epinephrine and 
norepinephrine), which are released during stress, are thought to play a 
crucial role via the induction of acute hemodynamic effects, e.g., 
increases in heart rate and blood pressure and the release of free fatty 
acids and other lipids (Krantz et al., 1982).
After endothelial injury has occurred (possibly due to hemodynamic 
or biochemical insult), a lesion forms. This lesion is the atheromatous 
plaque. Lipids and cholesterol and, possibly, platelets collect about 
the plaque which interferes with blood supply and leads to gradual 
enlargement. The end result is the clinical manifestations of CHD, 
i.e., angina, MI, and sudden death (Krantz et al., 1982). While the 
preceding discussion of the physiological process is tentative, it is 
not without support. Further, there is reason to believe that 
hemodynamic stresses are occurring more frequently and at a greater 
intensity in Type A individuals (Williams, 1978). The question now 
becomes one of how this process, i.e., stress, the TABP, and CHD, can be 
altered and the discussion turns to psychological intervention in the 
TABP.
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Psychological intervention in the Type A behavior pattern
Considering the preceding discussion, intervention in the TABP 
seems clearly indicated. The following sections will review the 
assessment of Type A behavior and published investigations of 
out-patient interventions in the TABP, as well as, interventions with 
CHD populations. Particular attention will be paid to methodological 
issues in the past research.
Assessment. As already discussed, the TABP is considered an 
integrated or over-learned behavior pattern which is elicited by 
particular stimulus situations or conditions. As presently formulated, 
these conditions involve challenges or possess a potential for 
uncontrollability. Consequently, assessment procedures which invoke 
these conditions are most likely to precipitate the appearance of the 
TABP. Thus, the Structured Interview (SI) was developed (Rosenman et 
al., 1964). Since 1964, the SI has been revised and the most recent 
revision uses a videotaped procedure (Friedman et al., 1981). The 
questions in the Videotaped Structured Interview, VSI, are reproduced in 
Table 2 and the scoring procedures in Table 3 (Friedman et al., 1981). 
The SI results in either a four category classification system of Types 
A-l (fully developed TABP), A-2 (incomplete and less extreme TABP), B (a 
relative absence of TABP), and X (equivalent Type A and B 
characteristics) or a five category system with category B yielding 
categories B-3 (a relative absence of TABP) and B-4 (fully developed 
Type B). However, most research has used a simple A-B dichotomy (Krantz 
et al., 1982). The scoring of the VSI, a new development designed to 
remove some of the Si's subjectivity, has not yet seen extensive use.
As a reading of the interview and scoring protocol indicates, the VSI is
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Table 2
Questions asked during videotaped interview
1 Mr. Jones, what is your occupation or profession?
2 Do you think that you are a hard-driving, oo-nonsense sort of 
achiever, or do you believe that you tend to do things in a 
rather leisurely manner?
3  Has your wife ever told you to take things easier or slow down? 
How does she put it? Does she still have to tell you to slow 
down?
4  Would your 20-year-old self have been proud or disappointed 
in what you have accomplished and are at this time? (Expand' 
if  necessary.)
5  Do you feel that most o f the important pans o f your life are 
now behind you? (Expand if necessary.) -
6  What do you think might have been the factors in or causes of 
your heart attack?
7 Some persons have claimed that they were glad they had suf­
fered a heart attack. Were you? (Expand.)
8 Do you admire and have as much respect and faith in doctors 
as your father and mother probably had? (Why not?)
9 Do you think your behavior had anything to do with your heart 
attack? (Expand.)
10 Do you walk/eat fast? After you have finished eating, do you 
like to sit and dawdle at the table, or do you like to leave and 
do something else?
11 If  there are 5 or 10 persons waiting to eat at a restaurant, would 
you wait? At a movie theater?
12 Most working people usually arise before 8:30 a .m . on week­
days although they may sleep longer on Saturdays and Sun­
days. Now in your case, during the weekdays, at what time do 
you, o h . .  . .*
13 When you are in the bathroom, do you sometimes do two things 
at once, such as reading trade or professional journals or wash­
ing your teeth as you shower?
14 (After asking about hobbies) When you have taken your black- 
and-white photographs (expand). . . . Well, after you did take 
the snapshots, the films, did you develop them? Uh . . . .*
13 If you tell someone that you will be somewhere at 2:00 p.m . ,  
will you be there?
’ Hesitation u> determine whether patient interrupts and finishes sentence.
16 What do you do it a car ahead of you in your lane is going too 
slowly? Have you ever sworn at such drivers? Has your wife 
ever told you to "cool it?”  How does she put it?
17 Do you frequently find yourself both listening to someone and 
also thinking about another subject? Do you find yourself doing 
this as your wife talks? What does she say when she discovers 
that you are doing this?
18 What sons of events, activities, or actions tend to irritate you?
19 What kind of car do yon drive? Most people, in San Francisco 
at least, probably-because of-the-hills, have theiT brakes 
checked or inspected or adjusted about every 6 months. Now 
in your case, in respect to your car, during the last 6 months, 
have you had its b rak es,.u h :n \c :^± r.
■ i
20 Do you have children?'When they were younger and you played 
games like checkers,-dominoesroncards, did you always let 
them win? W hy? . -_-jt
21 When you play a game-with your-contemporaries, do you play 
to win, or do you play fo r the fun-of it?
22 Do you frequently jus: daydream? What do you daydream 
about, or why don't you daydream?
23 Do you find that you sometimes like to time how long it takes 
you to do certain things like jogging, walking, auto trips, 
household chores, etc.?
24 Do you like to go shopping-with your.wife? Why or why not?
25 What would you do if you. and your wife were at a fine res­
taurant and she was becoming iilfrom the cigar smoke reaching 
her from a man sitting antbe-table Dext to yours? (Suppose the 
smoker said, "Drop-dead,-Mister” ? or suppose there was no 
other free table?)
26  What would yon do i f  you were-driving your car at 80 miles 
an hour on a busy highw a y to  get your sick wife to the hospital 
and suddenly you-spotted in your rearview minor the red light 
of a highway patrol -officer-obviously signaling you to turn off 
the highway? ; ^
27 AU of us have insecurities about certain things. What are your 
insecurities about?
28 In what way, if  any, have you changed since you had your 
heart attack?
from Friedman et al. (1981)
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Table 3
DUgoarfk Indicators of type A behavior
S can  So le  T: time urgency
A Psycho motor manifestations 
' 20 Ml Characteristic facial tautnesi expressing tension
20 M2 Rapid horizontal eyeball movements during ordinary conversarxxs
20 M3 Rapid eye blinking (over 40 blinks per minute)
20 M4 Knee jiggling o r rapid vigorous Upping o f  fingers
20 M5 Rapid, frequently dysrtiytfamic speech involving elision of terminal words of icntencm
IS M6 U p clicking during ordinary speaking
15 M7 Rapid-ticliic eyebnnv lifting
10 MR Head nodding when speaking
23 M9 Sucking in of air during speech
20 M10 Humming (tuneless)
23 Ml 1 Speech hurrying
IS M12 Tense posture
IS ' M13 Motorization accompanying responses
29 MI4 Expiratory sighing
20 MIS Rapid body movements
£ Direct behavioral tests (See questions 12,14, and 19 in Table I)
10 ■ Bl The interviewer, in posing a question whose answer is already clear fttrm its content, hesitates, becomes laboriously
tedious or repetitive, and then stammers. Does the subject tntenupi the stammering with an answer?
10 B2 Same procedures but a second questioa is employed
10 B l Same procedures but a third question is employed
C  Physiological indicators 
23 Cl Periorbital pigmentation
IS C2 Excessive forehead mi upper lip perspiration
0  Significant biographical content 
23 Dl Self-awareness of presence of Type A
20 D2 Foiyphasic activities (e.g., reads while driving, reads while using electric shaver, thinks of other matters during
conversation widt others)
20 D l Walks fast, eats fast, and does not dawdle at table (2 of 3)
20 D4 Makes fetish of always being on time under all circumstances
20 DS Has been told to slow down in working and living habits by spouse
10 D6 Difficulty in sitting and doing nothing
10 D7 Subject habitually substitutes numerals for metaphon in speech
■cab H: eseass competitiveness end hostility 
A Psychomotor manifestations 
23 Ml Characteristic facial set exhibiting aggression aod hostility (eye and jaw muscles)
23 M2 Charreteristie ticlike thawing beck of comer of lips, almost exposing teeth
23 M l Hostile, jarring laugh
23 M4 Use of clenched fist and table pounding or excessively forceful use of hands and fingers
23 MS Explosive, staccato, frequently unpleasant-sounding voice
20 MS Frequent use of obscenity
23 M7 Exhibition o f  irriratioa and rage when asked about tome past events in which the subject became angered
8 Direct behavioral tests
15 Bl The interviewer directly challenges dm validity of some oomment or behavior that the subject has reported. Does the
subject react tn-ahostilr or unpleasant manner?
13 B2 The-intsrviewerquestioes the subject about views on politics, race, women, competitus. Does the subjea respond with
ahtnluM. almmt angry gerwralivarinnv?
C  Significant biographical content
20 C l The subject reports having easily amused irritabilities if kept waiting for any reason or if driving behind a  car moving
too slowly
13 C2 The subjoctexpressca-feneral distrust of other people's motives—e.g., distrust of alcmism
20 C3 The subject repotts.alroostalways playing any type of game (even with young children) to win
Score;
Scale T -  
ScaleH •
Total -
from Friedman et al. (1981)
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designed to measure the stylistics of speech and behavior, in addition 
to the content of the responses. The stylistics have been shown to 
correlate more highly with the TABP (Krantz et al., 1982). The SI 
permits flexibility and is generally recognized as the most valid TABP 
measure (Blumenthal, 1982; Suinn, 1982). Although a global and somewhat 
subjective measure, interrater reliability has ranged from 74-90% 
(Blumenthal, 1982; Newlin, 1981) and test-retest reliability (one year) 
has been approximately 80% (Newlin 1981). While Rosenman (1977) states 
that the SI is the only valid technique for assessing the TABP, other 
measures have been developed and the Review Panel (1981) concluded that 
two of these, the Jenkins Activity Survey and the Framingham Type A 
Scale, have demonstrated validity.
The more well known of the two is the Jenkins Activity Survey, the 
JAS (Jenkins, Rosenman, & Friedman, 1967), which is a self-administered 
questionnaire originally developed for use in the WCGS. The JAS 
provides an overall Type A score and three subscales for speed and 
impatience, hard-driving, and job involvement. The subscales were 
derived by factor analysis and all four scales are continuous. 
Test-retest reliability coefficients over a one year period have ranged 
from .65 to .80 (Newlin, 1981). Because the JAS is a self-report 
measure, it relies on content and self-perceptions only and, thus, may 
be subject to distortion. In fact, Friedman (1978) states that Type A 
individuals often have little insight into their Type A behavior and are 
often totally inaccurate in their responses to questionnaires. More 
recently, however, Herman, Blumenthal, Black, and Chesney (1981) 
reported a significant relationship between self-ratings of Type A 
characteristics and SI classification. More importantly, the JAS Type A
22
scale is in agreement with the SI in about 65-70% of all cases (Krantz 
et al., 1982) and in 90% of cases when considering JAS scores ± one 
standard deviation from the mean (Newlin, 1981).
As Newlin (1981) notes, the ultimate validity of each measure must
rely upon the prediction of CHD events and both measures, the SI and 
JAS, have been shown to predict CHD endpoints (atherosclerosis and 
recurrence both retrospectively and prospectively) (Jenkins, 1978). 
However, despite acceptable concordance rates, correlations between the 
JAS and the four point SI (Al, A2, B, and X) have been rather low, 
ranging between .25 and .40 (Krantz, et al., 1982). These results 
strongly suggest that the JAS and the SI are measuring different 
components of Type A behavior and that both should, consequently be used 
in research when feasible.
Among the additional measures of the TABP that have been developed, 
only one, the Framingham Type A Scale (Haynes, Feinleib, Levine, Scotch, 
& Kannel, 1978; Haynes et al., 1980) has been found to be a valid 
predictor of CHD risk (Review Panel, 1981). The Framingham Scale may 
also prove useful with subject populations dissimilar to the WCGS for 
the association of the TABP with angina and CHD was as high in women as
in men (Haynes et al., 1980). Also noteworthy are the two measures
developed by Bortner (1969) and Bortner and Rosenman (1967), one of 
which is a rating scale and the other a behavioral performance test.
Both measures have demonstrated significant correlations with the SI and 
to distinguish between CHD cases and controls but have not been 
validated against CHD occurrence (Suinn, 1982). The final Type A 
measure is the VSI which has received extensive use but only in the 
Recurrent Coronary Prevention Project (RCPP). As the RCPP has
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progressed, the scoring of the VSI has changed from the procedure 
illustrated in Table 3 to one in which the 38 indicators are weighted on 
a scale from one to three, reflecting their intensity (Powell et al., 
1984). Using dichotomized A-B categories, the VSI classified 83.6% of 
subjects in agreement with the SI. Satisfactory reliability 
coefficients, .74-.79, and significant correlations with the Jenkins and 
Framingham Scales have been reported (Powell et al., 1984). As already 
discussed, significant reductions in VSI measured TABP have been 
associated with reductions in coronary events.
In summary, three assessment instruments, the Framingham scale, the 
JAS, and the SI, have been validated against CHD occurrence and of the 
three the JAS and the SI have been used most extensively. The VSI, a 
derivative of the SI, has been validated against the reoccurrence of CHD 
events. However, the Bortner rating scale (1969) has shown promise and 
been used in outcome evaluation research (Jenni & Wollersheim, 1978). 
Considering the ease of administration and scoring of both the 
Framingham and Bortner scales, there seems little reason to preclude 
their usage. In fact, a comparison and analysis of the relative 
contributions of the five measures may help elucidate the association 
between behavior and CHD. To the author's knowledge, this research has 
yet to be undertaken.
Non-CHD populations. While Friedman and his coworkers have stated 
that intervention in non-CHD populations is extremely difficult, if not 
fruitless (e.g., Friedman, 1979; Friedman et al., 1981), Thoresen,
Telch, and Eagleston (1981) have correctly noted that reserving 
treatment for only post-MI patients is likely offering too little, too 
late, to too few. Consequently, researchers have attempted to alter the
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TABP in clinically healthy populations. In Suinn's review of the 
literature (1982), he notes that seven studies have attempted to alter 
Type A behaviors in healthy persons. However, three of the seven are 
unpublished and, thus, are generally unavailable for critical review.
Of the four published studies (Jenni & Wollersheim, 1978; Levenkron, 
Cohen, Mueller, & Fisher, 1983; Roskies, Spevack, Surkis, Cohen, & 
Gilman, 1978; Suinn & Bloom, 1978), the report by Jenni and Wollersheim 
also included several subjects with CHD and is, therefore, discussed in 
a later section.
All of the treatment programs involved some degree of anxiety 
management or relaxation training. In particular, Suinn and Bloom 
(1978) focused on anxiety management with an emphasis on muscle 
relaxation and covert rehearsal of successful coping while Roskies et 
al. (1978) focused on relaxation with record keeping. Finally, 
Levenkron et al. (1983) utilized a more comprehensive approach 
integrating several self-control procedures, including relaxation. An 
additional study by Blumenthal, Williams, Williams, and Wallace (1980) 
evaluated the effects of exercise on the TABP.
As the reader may conclude, summary statements based upon four 
studies must be tentative. In addition, all four studies suffer 
methodological shortcomings. The first problem is the limited use of 
comparison or control groups. Blumenthal et al. (1980) used only a 
treatment condition, i.e., no controls, and Suinn and Bloom's (1978) 
report lacks a comparison treatment condition. In contrast, Roskies et 
al. (1978) used a psychotherapy condition which attempted to provide a 
corrective emotional experience and Levenkron et al. (1983) compared 
their comprehensive behavior therapy condition to group support and
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brief information conditions. The second shortcoming is the use of the 
JAS for TABP assessment (Blumenthal et al., 1980; Levenkron et al.,
1983; Suinn & Bloom, 1978). The reader will recall that the JAS is, 
perhaps, not the preferred method of assessment. Conversely, Roskies et 
al. (1978) used the SI for subject selection but did not evaluate the 
TABP as an outcome measure. While granting that research into the 
alteration of the TABP is in its infancy and that researchers are 
seeking to demonstrate any impact, methodological inadequacy merely 
prolongs this infancy.
Despite the afore-mentioned problems, the results are hopeful and 
suggest that the TABP can be altered. Blumenthal et al. (1980) reported 
significant overall TABP changes for their Type A subjects but not for 
their Type B subjects. The three JAS factor scales did not demonstrate 
change. Suinn and Bloom's results also indicated significant change for 
treated subjects compared to waiting list controls but only on two of 
the JAS factors, speed and impatience and hard-driving. Roskies et al.
(1978) did not report treatment differences but did report changes in 
both treatment conditions (behavior therapy and psychotherapy) on a 
measure of time pressure. Similarly, in the Levenkron et al. (1983) 
report both groups receiving treatment demonstrated similar significant 
change in the TABP, i.e., overall JAS, JAS hard-driving, JAS job 
involvement, and Framingham Type A scores. However, only the 
comprehensive behavior therapy group improved on JAS speed and 
impatience scores.
Physiological changes which were also noted included significant 
beneficial changes in cholesterol (Roskies et al.), high-density- 
lipoprotein (Blumenthal et al.), systolic blood pressure (Blumenthal et
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al.; Roskies et al.), diastolic blood pressure (Blumenthal et al.), 
triglycerides (Levenkron et al.), and weight (Blumenthal et al.; Roskies 
et al.). Levenkron et al. also noted improved heart rate and blood 
pressure responses to a stressful subtraction task but improvement was 
not related to treatment condition. Unexpected physiological results 
included an increase in triglycerides in Suinn and Bloom's treatment 
group and an increase in low-density-lipoprotein in Levenkron et al.'s 
behavior therapy condition.
A conclusion based upon these reports must, of course, be 
conservative but the preceding evidence does suggest that the TABP and 
physiological concomitants can be altered in healthy subjects.
However, all interventions, exercise, psychotherapy, and relaxation/ 
behavior therapy, seem to be equally effective. Because all four 
reports have shortcomings (Razin, 1982; Suinn, 1982), further 
investigation and replication is clearly indicated.
CHD populations. As already mentioned, Friedman (1979) does not 
believe that intervention can achieve any significant success unless 
patients have already suffered an infarction. He lists five reasons why 
this is so: (a) the TABP is generally considered a prideful possession
by those with the TABP, (b) Type A's have the "other fellow" syndrome, 
i.e., others will suffer from CHD but not them, (c) because Type A's are 
pragmatic they do not understand how an emotional complex can result in 
an actual lesion, (d) almost all cardiologists are Type A's and do not 
have the patience to try and eliminate the more observable risk factors, 
e.g., diet, smoking, and exercise, and (e) it is not easy to initiate 
and maintain an indefinitely prolonged prophylactic regimen that never 
demonstrates unequivocally its effectiveness (Friedman, 1979; Friedman
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et al., 1981). In the same vein, post-MI patients can have their TABP 
altered because (a) they can no longer fool themselves that the TABP may 
lead to CHD in others but not themselves, (b) during the prolonged 
recovery from the MI, they find time to review their past habits and way 
of living, and (c) they frequently experience frightening symptoms 
(e.g., angina, palpitations, dyspnea, and easily induced fatigue) when 
they yield to Type A behavior (Friedman, 1979; Friedman, et al., 1981). 
While the above statements have a certain face validity, they are based 
upon observation rather than empirical investigation.
Assuming that the above statements are, in fact, true and that the 
TABP can be altered in patients who have experienced a cardiac event, 
what does the experimental evidence indicate? Unfortunately, it is 
premature for a firm conclusion (Suinn, 1982) and findings should be 
considered no more than tentative (Razin, 1982). In fact, many of the 
recent statements concerning the TABP have been prescriptive rather than 
evaluative (e.g., Friedman, 1979; Friedman et al., 1981; Gentry, 1978; 
Suinn, 1978) or have been review articles lamenting the paucity of 
adequate research (e.g., Doehrman, 1977; Frank, Heller, & Kornfeld,
1979; Razin, 1982; Suinn, 1982; Thoresen et al., 1981; Williams, 1981).
The available published research of psychological interventions in 
the TABP is summarized from a methodological standpoint in Table 4. 
Nondata based publications have also appeared in the literature (e.g., 
Bloom, 1979; Hoebel, 1976; Mone, 1970) but will not be discussed due to 
their lack of data and, therefore, the difficulty in drawing 
conclusions. Four methodological problems are immediately apparent from 
Table 4: (a) in no case was intervention compared with a credible
attention/placebo control condition and a no treatment condition, (b) in
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no case were patients controlled for the severity of CHD, (c) in only 
one report (Ibrahim et al., 1974) was patient assignment entirely 
random, and (d) in only two studies (Jenni & Wollersheim, 1978; RCPP 
[e.g., Friedman et al., 1984; Powell et al., 1984]) were subjects 
evaluated for changes in the TABP. However, Jenni and Wollersheim 
elected to use the Bortner scale as an outcome measure, although 
patients were selected with the SI. The reader will recall that the 
Bortner scale is not a preferred method for TABP assessment (Review 
Panel, 1981). In the RCPP, the VSI was used at entry and the three year 
follow-up. Thus, the RCPP stands alone in assessing the TABP as an 
outcome measure though the demonstrated validity of the VSI is limited. 
An additional problem with CHD interventions is attrition which is most 
often discussed indirectly, if at all. For example, Suinn (1974; 1975) 
and Suinn, Brock, and Edie (1975) make no mention of attrition.
Attrition to the final data collection point seems to be between 20% and 
25%, but may be as high as 50% as occurred in Bilodeau and Hackett's 
(1971) study. Additional attrition rates include the following: 10 of
42 (Jenni & Wollersheim, 1978), 8 of 34 (Roskies et al., 1979), 7 (4 
drop-outs and 3 deaths) of 61 (Rahe, Ward, & Haynes, 1979), 4 of 16 
(Adsett & Bruhn, 1968), 19 of 118 (Ibrahim et al., 1974), and 325 of 
1035 (Friedman et al., 1984). To Friedman et al.’s credit only 77 of 
their patients were unavailable for the three year follow-up. As Table 
4 illustrates, virtually the only common theme among the 11 studies is 
that at least some of the participants had some CHD symptomatology which 
was predominantly an MI. As already stated concerning the non-CHD 
studies, inadequate methodology seems to reflect the state of the field,
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Table 4
Patient Characteristics of Interventions with CHD Samples
Study
Controlled
CHD Variables or Type A Assessment
Population Pretreatment Analyses______Entry Outcome
Adsett & Bruhn (1968; also Bruhn et al., 1971)
post-MI
Bilodeau & Hackett (1971) 
post-MI 
(first) 
Thockloth et al. (1973) 
post-MI
Ibrahim et al. (1974) 
post-MI
Sex (male), married,
<55 yo, SI yr post- 
MI, problem adapting 
to cardiac status, high 
drive & frustration. 
Controls: age, sex, & 
race.
Sex (male), <55 yo
<60 yo, sex (male),
S2 wks as in-pt, 
work status
History or ECG of MI, 
hospitalized in ICCU, 
35-65 yo
No
No
No
No
No
No
No
No
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Table 4 (cont.)
Study
CHD
Population
Controlled 
Variables or 
Pretreatment Analyses
Type A Assessment 
Entry Outcome
Yes No
(Method?)
Yes No
(Method?)
Suinn (1974)
post- ?*
cardiac
Suinn (1975)
35 post- ?
MI 2 CAD
Suinn et al. (1975) Same as Suinn (1974)
Rosenman & Friedman (1977)
? . Sex (male)
Jenni & Wollersheim (1979)
7 Ss with Sex (male), high
history of Type A
heart attack 
Naismith et al. (1979)
post-MI <60 yo, sex (male),
diagnosis 
Rahe et al. (1979; also 1973, 1975)
post-MI Age, smoking, height,
(first) weight, Norris index,
location of infarct
Yes No
(Method?)
SI Bortner
No No
No No
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Table 4 (cont.
Study______
Roskies et al.
Friedman et al
Langosch et al
Controlled
CHD Variables or Type A Assessment
Population Pretreatment Analyses_____ Entry Outcome
(1979)
7 Ss with 
CHD symptoms 
on stress 
test
. (1982; 1984; 
post-MI
Type Al, 39-59 yo, full SI No
time job, >$25,000
income, no medication
affecting outcome
medications, sex (male)
Powell et al., 1984; Thoresen et al., 1982) 
<65 yo, 56 mos. post- VSI VSI
MI, 56 mos. no smoking, 
non-diabetic
, (1982) 
post-MI (?) Sex (male), in-patient 
medically cleared_____
No No
* can not be determined from publication
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Table 5
Treatment Characteristics of Interventions with CHD Samples
Study Conditions
Ini­
tial Random
N Age Assignment
Duration 
Treatment Follow- 
Sessions up
Adsett & Bruhn (1968; also Bruhn et al., 1971)
Group therapy 
No treatment 
Dropouts
Bilodeau & Hackett (1971)
Group therapy
Thockloth et al. (1973)
Planned Rehab. 
No Rehab.
Ibrahim et al. (1974)
Group therapy 
No treatment
Suinn (1974)
Cardiac stress 
mngmt training 
(CMST)
No treatment
10
6
0
10
50
50
58
60
10
47.5
Random
selection
Yes
Yes
10 9 yrs.
12 None
? 3-18 mos. 
50 6 mos.
5 None
10
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Table b ^cont.;
Study Conditions
Ini­
tial
N Age
Random
Assignment
Duration 
Treatment Follow- 
Sessions up
Suinn (1975)
CMST 10 52.1 9 5 None
CSMT (replication) 17 52.6 5 None
No treatment 10 53.7
Suinn et al. (1975) Same as Suinn (1974)
Rosenman & Friedman (1977)
Psychoanalytic 12 9 9 9 None
group therapy (18 mos.)
Jenni & Wollersheim (1979)
CSMT 14 42.1 Yes 6 6 wk.
Cognitive-
Behavioral 14 42.6 (CHD:No) 6 6 wk.
No treatment 14 42.8
Naismith et al. (1979)
Intensive Rehab 76l- 50.5 Yes 9 6 mos.
Standard Rehab. 77j 9 6 mos.
Rahe et al. (1979; also 1973; 1975)
Group therapy 22 46.9 Yes 6 4 yr.
No treatment 22 51.2 Yes 6 4 yr.
Group therapy 17 48.5 No 6 3 yr.
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Table 5 (cont.)
Study Conditions
Ini- Duration
tial Random Treatment Follow-
N Age Assignment Sessions up
Roskies et al. (1979)
Behavioral 
(CHD Ss) 
Behavioral 
(no CHD) 
Psychotherapy 
(no CHD)
7 49.5
14 48.3
No
Yes
Yes
14
14
14
6 mos.
6 mos.
6 mos.13 46.9
Friedman et al. (1982; 1984; Powell et al., 1984; Thoresen et al., 1982) 
Cardiologic
24 in 3 yrs.
Yes
No
No
44 in 3 yrs.
counseling 270 53.4 Yes
Type A 
Behavioral
counseling 614 53.1
No treatment 151 54.2
Langosch et al. (1982)
Stress Mngmt. 46 48.1
Relaxation 43 50.4
No Treatment 30 49.1
8
8
6 mos. 
6 mos.
* can not be determined from publication
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i.e., investigators have sought to demonstrate any impact upon CHD 
patients. However, the time seems ripe for a methodologically sound 
investigation before intervention strategies become more and more 
complex.
Despite the preceding shortcomings, research with CHD patients does 
suggest that intervention can be successful but the most effective type 
of intervention has yet to be identified. However, a major problem in 
comparing outcomes across studies is that the majority of studies have 
developed their own self-report measures and it is not clear how these 
measures correlate with standardized Type A assessment and CHD (Suinn, 
1982). Obviating this problem is the use of clinical CHD endpoints but 
only four studies were of sufficient duration to report recurrent CHD 
events (Adsett & Bruhn, 1968; Friedman et al., 1984; Ibrahim et al., 
1974; Rahe et al., 1979). All but Adsett and Bruhn reported that 
treatment reduced the occurrence of CHD events, i.e., reinfarction. 
However, comparisons of treatment conditions can only be made in 
Friedman et al. who reported that the behavioral counseling was more 
effective than cardiologic counseling with a three year cumulative 
cardiac recurrence rate of 7.2% vs 13.2%, p<.005. The behavioral 
counseling group was also more effective than the no treatment 
comparison condition, a recurrence rate of 14%.
The evidence concerning other than CHD endpoints is less 
consistent. As Table 4 indicates, only two studies assessed the TABP as 
an outcome measure. Jenni and Wollersheim (1978) reported significant 
changes on the Bortner scale but only among high Type A's (presumably, 
Type Al on the SI but not defined) and only in the cognitive behavioral 
treatment condition. In the most recent RCPP report (Friedman et al.,
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1984) , significant reductions in the VSI measured behavior pattern had 
occurred among active participants in both treatment conditions with the 
behavioral condition evidencing significantly greater reductions than 
the cardiologic counseling condition. These results were corroborated 
by questionnaires completed by participants, spouses, and work 
colleagues and were generally robust even when considering all initially 
enrolled participants. Thus the RCPP offers the strongest evidence, at 
present, that the behavior pattern can be successfully ameliorated. 
Physiological changes have also been reported, but problems exist with 
the interpretation of the results. For example, Suinn (1975) reported 
"substantial" changes in lipid (cholesterol and triglycerides) levels in 
the cardiac stress management training (CSMT) conditions but did not 
report significance levels. In addition, weight loss in the CSMT 
conditions, versus weight gain in the no treatment condition, may have 
accounted for these differences. Additional studies have reported a 
decrease in cholesterol (Adsett & Bruhn, 1964; Roskies et al., 1979; 
Friedman et al., 1984), no change in cholesterol (Ibrahim et al., 1974; 
Rahe et al., 1979), and an increase in cholesterol (Jenni & Wollersheim, 
1978). Similar contradictory results have been reported for blood 
pressure with Roskies et al. reporting beneficial change and Adsett and 
Bruhn, Ibrahim et al., and Jenni and Wollersheim reporting no changes. 
Friedman et al. (1984) reported reductions in hypertension and 
congestive heart failure but attributed these changes to a different 
classification format at follow-up. Friedman et al. also reported a 
significantly greater incidence of angina in the cardiologic condition 
compared to the behavioral condition. This difference was not present 
at entry. No differences in drug ingestion, arrhythmias, or bypass
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surgeries were noted between the two conditions. Interestingly, none of 
the preceding investigations challenged subjects with a stressor and 
evaluated subject response. The reader will recall that responding to 
stressful situations with Type A behavior is hypothesized to be critical 
to the evolution of CHD. The fact that subjects have not been 
challenged is even more curious considering the intervention emphasis 
upon relaxation and stress management.
In summary, a review of the published literature to date does not 
allow a conclusion to be made concerning the efficacy of psychological 
interventions in CHD populations. Possibly, intervention does have an 
impact upon future CHD events but the short-term results of short-term 
treatment programs are open to speculation. While intervention may have 
an impact upon the TABP (e.g., Jenni & Wollersheim, 197.8; Friedman et 
al., 1984), methodological inadequacies and a multiplicity of 
individually developed outcome measures preclude any firm statements. 
Problem
As the preceding literature review indicates, the Type A individual 
responds to stressful or challenging situations in a manner which places 
him or her at risk for the development of coronary heart disease. Or if 
CHD is already present, the likelihood of a recurrent CHD event is 
increased in the individual who manifests the Type A behavior pattern. 
The present author believes that the research evidence supports this 
conceptualization and, also, believes that Friedman's (1979) statements 
that the TABP is more easily modified in CHD patients (than asymptomatic 
non-patients) are accurate. Therefore, this study was designed to 
determine if a methodologically sound behavioral intervention can affect 
the TABP and its cognitive, behavioral, and physiological concomitants.
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As already mentioned, various authors (e.g., Friedman, 1979; 
Friedman et al., 1981; Gentry, 1978; Thoresen et al., 1981; Suinn, 1982) 
have hypothesized upon an effective treatment intervention. To briefly 
summarize, a multi-modal rather than single method approach was utilized 
in order to maximize the likelihood of effecting a positive change 
(Suinn, 1982). As outlined by Gentry (1978), the treatment program 
focused upon (a) changing the antecedents of Type A behavior, e.g., 
altering schedules to avoid situations that elicit Type A behaviors, (b) 
changing personal responses to stressful situations, e.g., replacing 
Type A behavior with relaxation and altering cognitive behavior, and (c) 
changing the consequences of behavior, e.g., overt and covert reinforce­
ment for non-Type A behavior and overt and covert response cost for Type 
A behavior. There was, also, an emphasis upon homework and self­
monitoring of individual patient progress in order to insure both skills 
acquisition and generalization (Friedman, 1979; Friedman et al., 1981).
The behavioral treatment program for stress management was compared 
with a credible attention/placebo condition and a waiting list control 
condition. The attention/placebo condition was equated with the stress 
management condition for number of sessions and duration of sessions.
The format of the attention/placebo condition was non-directive group 
therapy with an emphasis on discussion and catharsis rather than skills 
acquisition. The group leaders were non-directive and acted as group 
facilitators.
The present study, also, represented a major improvement over past 
studies of CHD patients (see Table 4) through (a) the use of complete 
random assignment to all experimental conditions, (b) the use of the 
Structured Interview for assessment (with patient assignment to
39
conditions from stratified blocks) and outcome, and (c) secondarily
controlling for the severity of CHD through the use of an index of
coronary artery disease and the systolic ejection fraction, a measure of
left ventricular heart function (the reader is referred to the method
section for a further discussion of these measures). Hypothesis 1
predicted that participation in the behavior stress management program
would effectively alter the TABP as assessed by the SI. Hypothesis 1
was formally stated as:
Hypothesis 1: Among the three experimental conditions, 
alteration of the TABP, as assessed by the SI, will be 
superior among patients receiving the behavior stress 
management program.
While additional measures of the TABP (the Bortner and Framingham 
scales and the JAS) were utilized no specific hypotheses were offered 
as these measures have either not been demonstrated to be as predictive 
of initial and recurrent CHD events, i.e., the JAS, or have had limited 
use, i.e., the Bortner and Framingham scales. In addition, no 
hypotheses were offered with respect to the therapeutic outcome of 
either the group therapy condition or the no treatment condition. 
Although the group therapy condition was not considered to be an inert 
treatment condition, previous studies have reported similar conditions 
to either resemble the active treatment condition or the no treatment 
condition. Thus, no hypotheses specific to the group therapy and no 
treatment conditions were offered.
As the preceding discussion of stress and the TABP indicated, the 
Type A individual becomes particularly aroused in stressful, challenging 
situations. However, previous interventions have not examined the 
possibility that intervention had/did not have an effect upon patients' 
response to stress. Therefore, this investigation utilized two
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stressors to examine the actual efficacy of the stress management 
program in handling stress. The first stressor was the Quiz 
Electrocardiogram (QE) developed by Schiffer, Hartley, Schulman, and 
Abelmann (1976). The QE, delivered in a tape recorded format, consists 
of 35 questions resembling intelligence quotient test items. Heart rate 
and blood pressure values during the quiz have shown significantly 
greater elevations in business executives with angina compared with 
executives without angina (Schiffer et al., 1976) and in post-MI 
patients compared with non-CHD controls (Sime, Buell, & Eliot, 1980).
The second stressor was a cold pressor task involving immersion of the 
patient's hand into an insulated bucket of ice water, 1°-3°C. As with 
the stress quiz, the cold pressor task has been shown to reliably 
produce heart rate and blood pressure elevations (e.g., Dembroski et 
al. , 1979). During both stressors, heart rate and blood pressure were 
monitored.
Hypothesis 2 predicted that patients who participated in the
behavioral stress management program would demonstrate improved
cardiovascular performance in response to both stressors while subjects
in both control conditions would fail to demonstrate improved
performance. Hypothesis 2 was formally stated as follows:
Hypothesis 2: Patients who participated in the behavioral 
stress management program will demonstrate improved 
cardiovascular performance, i.e., lower heart rate and 
blood pressure elevations, on both the stress quiz and 
cold pressor task compared to the two control conditions.
While additional dependent measures were examined, prior investiga­
tions have been so contradictory that hypothesized outcomes were 
precluded. Thus, this study was designed to determine if a behavioral 
stress management program would have a demonstrable effect upon the Type
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A behavior pattern in diagnosed CHD patients and if the stress 
management program could demonstrably alter CHD patients' response to 
stressful events.
Method
Subjects
Subjects, henceforth identified as patients, were patients selected 
from the active participants in the Veterans Administration Cardiac 
Rehabilitation Program in Augusta, Georgia. Recruitment was done 
on-site via posted notices and brief discussions of the proposed program 
before and after regularly scheduled exercise activities. Inclusion 
criteria were: (a) current participation in the Cardiac Rehabilitation
Program , (b) permission of the attending cardiologist, and (c) signing 
of informed consent (see Appendices 1, 2, and 3). Interested patients 
were urged to speak with the investigator at greater length and if they 
continued to be interested in participation, they were asked to schedule 
a pretreatment interview with the investigator. During the interview, 
the program was thoroughly discussed, informed consent was obtained, and 
pretreatment assessment completed.
A total of 52 patients were assessed for the TABP. This patient 
sample represented 65% of the patients on the cardiac Rehabilitation 
rolls who had attended at least one exercise session during the two week
2 Some elaboration of criterion "a" is pertinent. While all volunteer 
Rehabilitation patients were assessed, those patients exhibiting the 
greatest degree of the TABP were given priority for participation, and 
only those patients exhibiting the TABP were considered in data 
analyses. Friedman et al., (1981) reported that among 50 randomly 
selected post-MI patients the mean VSI score was 287 (s.d.=90 and 
range=135-575). A score greater than 88 indicated some degree of the 
TABP. In a corresponding manner, and SI rating of Al, A2, or X 
indicates a preponderance (Al and A2) or even mix (X) of Type A 
characteristics. Therefore, patients classified as B3 or B4 were 
eliminated from data analysis.
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period during which the interviews were conducted. These patients also 
constituted 83% of the rehabilitation programs’ regular attendees, i.e., 
attended at least four of six exercise sessions during this same two 
week period. Thus, the patient sample was representative of those 
patients who were sufficiently motivated to maintain a physical activity 
level that might potentiate the progression of their CAD. Among the 52 
patients, 47 (90% of the sample) were rated as Type Al, A2, or X (see 
Figure 1; Murphy, 1984) and 5 patients (10% of the sample) were rated as 
Type B3 or B4. These five patients were eliminated from the data 
analysis. In addition, one pilot patient received the treatment program 
individually and one patient withdrew from participation prior to 
completion of the pretreatment assessment. These two patients were also 
eliminated from data analyses. Thus, the final sample consisted of 45 
patients.
Additional patient characteristics are shown in Table 6. As can be 
seen in the Table, the average patient was a married older gentleman who 
had a high school education. He had been retired for 6-7 years and had 
spent approximately half of this time in the rehabilitation program.
With respect to CAD, patients had significant disease but relatively 
normal ejection fractions. Almost all patients had sustained an MI and 
a majority had received bypass surgery. Despite multiple medications, 
most patients continued to be symptomatic, e.g., angina, shortness of 
breath. With respect to traditional risk factors, most patients had 
stopped smoking, were moderately overweight, had a positive family 
history of cardiovascular disease, and had been diagnosed as 
hypertensive. In sum, this patient sample was not healthy and had 
experienced the consequences of heart disease for many years.
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Figure 1. Patient distribution by the Structured Interview.
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Table 6
Values for Patient Variables at Pretreatment
Variable Behavioral
Age (mean)
Married (n)
Education (mean)
Retired (n)
Years Retired (mean)
Smoking^ (mean)
Weight (mean)
% Overweight (mean)
Years in Rehabilitation (mean) 
Cardiac Catheterization (n)
CAD Score (mean)
14
58.7 (7.5)
12
4.1 (1.7) 
12
6.1 (3.3)
3.5 (2.5)
191.2 (25.2)
28.3 (15.0)
3.6 (2.0) 
13
22.2 (8 . 6)
Conditions
Supportive_________ Waiting List
16
61.5 (4.9)
15
4.2 (1.6)
14
6.8 (3.9)
2.0 (1.9)
181.3 (23.8)
22.7 (12.7)
3.5 (2.1)
13
20.7 (9.1)
15
60.2 (5.9)
13
4.0 (2.0) 
13
7.0 (4.2)
2.3 (1.5)
184.4 (29.9)
24.4 (16.6)
4.6 (2.5)
15
22.4 (8.7) 
(table continues)
Conditions
Variable__________________________Behavioral_________ Supportive_________ Waiting List
Ejection Fraction (mean) 63.5 (8.0) 67.3 (13.5) 59.9 (16.2)
Myocardial Infarctions (n) 12 15 14
Artery Bypasses (n) 8 7 10
Medication: Beta Blockers (n) 13 15 13
Calcium Channel (n) 6 5 2
Diuretics (n) 8 11 6
Diagnosed Hypertension (n) 10 11 6
Positive Family History (n) 6 10 5
Presently Symptomatic (n) 10 13 10
Note. Standard deviations are enclosed in parenthesis.
Code: 1 (0-4 years); 2 (5-8 years); 3 (some high school); 4 (high school graduate); 5
(trade or business school); 6 (some college); 7 (college graduate); 8 (post-graduate). 
^Code: 0 (never); 1 (stopped (510 years); 2 (stopped 1-9 years); 3 (stopped <1 year); 4
(<5/day); 5 (5-9/day); 6 (10-19/day); 7 (20-29/day); 8 (530/day).
47
Therapists
The experimenter served as the primary therapist for both treatment 
conditions and was assisted (in both conditions) by a clinical nurse 
specialist with extensive experience with cardiac rehabilitation 
patients. In order to control for unintentional bias, i.e., the 
experimenter leading both groups, a procedural check (see Appendix 4) 
was used to assess treatment credibility (Kazdin, 1979). In addition, 
videotapes of the second and last sessions were made for both groups. 
Following the conclusion of treatment, the videotapes were played for 
the staff of the Rehabilitation program. The staff then rated each 
treatment program using the credibility questionnaire.
Experimental Design
Patients were randomly assigned from stratified blocks according to
scores on the VSI to three experimental conditions: (a) behavioral
stress management, (b) group psychotherapy which was also intended to
control for non-specific treatment variables, and (c) no treatment
control condition (see Table 7). All qualified patients were assigned.
%
As previously mentioned, an attempt was made to evaluate the severity of 
CHD. Severity was examined by the use of the ejection fraction and an 
index of the severity of CAD. The ejection fraction is a method for 
evaluating myocardial performance which is determined by coronary 
arteriography (Dodge & Sandler, 1974). The formula for the ejection 
fraction is (EDV-ESV)/EDV where EDV is the end-diastolic volume (i.e., 
the left ventricular volume at the end of expansion) and ESV is the 
end-systolic volume (i.e., the left ventricular volume at the end of 
contraction). Ejection fractions for normal adults show a narrow range 
of variation about a mean of .67, while an ejection fraction below .50
Table 7
Study Protocol
Procedure
Week 
2 3-13 14 15
Recruitment X
Review Reports of
Catheterization X
Structured Interview X X
Paper and Pencil
Questionnaires X X
Blood Work X X
Stress Quiz X X
Cold Pressor X X
Randomization X
a
Group Meetings
X
X
X
X
X
X
X
X
X
X
X
10 meetings over 11 weeks due to holidays.
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is usually considered abnormal and indicative of myocardial disease 
(Dodge & Sandler, 1974). Patient arteriograms were also be examined to 
determine the degree of occlusion in the four coronary arteries (see 
Figure 2 which is a schematic of the four coronary arteries) which 
encircle the heart and provide the heart with oxygen and nutrients. The 
arteriographic report (see Figure 3), which is computerized, was scored 
using a scoring system which parallels the report (Conti, 1977), i.e., 
normal = 0, less than 25% = 1, 25 - 49% = 2, etc. The overall degree of 
CAD for the four arteries was represented by a cumulative 
score for the 15 arterial branches. The use of the arteriographic 
report in this manner, i.e., ejection fraction and CAD severity, would, 
hopefully, help clarify the discrepant results correlating the TABP with 
severity of coronary occlusion.
Treatment Procedure
The proposed intervention program for both treatment conditions 
consisted of 10 weekly treatment sessions of approximately 1^ hours 
duration over a ten week period. Assessment was performed prior to the 
first session and following the last session. This protocol is shown in 
Table 7.
The behavioral stress management program (SMP) consisted of 
structured teaching, demonstrations, in-session practice, and handouts. 
Patients also received homework (inter-session practice) and self­
monitored their adherence to program procedures. As outlined in Table 
8, the SMP began with an overview of Type A behavior, stress, the 
interaction of the TABP and stress, and how Type A behavior and stress 
might be altered/managed. The overview proceeded to a discussion of 
individual patient problems which were targeted for self-monitoring
C O R O N A R Y  ARTERIO GRAM
Figure 2
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Figure 3
Arteriographic Report of Arterial Occlusion
Branch Normal Collaterals Small 25% 50% 75% 90% Collaterals 99% 100%
RCA 1
2
3
4
LCA 5
LA D  6
7
8
9
10
C IRC  11
12
13
14
15 .
Table 8
Behavioral Stress Management Program
Session:
Pre-treatment Interview: Brief Description and Informed Consent
Attendance Contracts 
Structured Interview 
Stress Tests 
Paper and Pencil Tests 
Blood Work
I: Introduction: Type A Behavior, Stress and Interaction
Alteration/Management of Type A Behavior/Stress 
Problem Identification 
Self-monitoring (throughout treatment)
2: Review of Self-monitoring
Introduction to Problem Solving
3: Further Problem Solving
a) Altering stimulus conditions
4: Introduction to S-O-R Model and Relaxation
5: Further Relaxation
a) Condensation of relaxation procedures
6: Further Relaxation
a) Imaginal stressful events
7: Introduction to Cognitive Processes
a) Self-instruction
b) Irrational thoughts
8: Further Cognitive Processes 
a) Thought stopping
9: Introduction to Reinforcement and Punishment 
a) Overt and covert procedures
10: Further Reinforcement and Punishment 
a) Contingency contracting 
Wrap-up and Congratulations
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during the week. At session two, the self-monitoring records were 
thoroughly reviewed to stress their importance, insure accuracy, and 
promote continued adherence. This review led into a discussion of how 
to solve problems using examples provided by the group. The emphasis 
was upon stimulus conditions which elicit Type A behaviors/stress. The 
focus upon problem solving continued to session four. At session four, 
the S-O-R model of behavior was formally introduced (patients had been 
monitoring S-O-R variables) and progressive relaxation training 
(Bernstein & Borkovec, 1973) began. Relaxation was demonstrated and 
practiced by the patients. Homework consisted of twice a day practice 
of at least 15 minutes duration. Sessions five and six consisted of 
further relaxation training with condensation of the procedures (seven 
muscle groups, four muscle groups, and recall) and imaginal presentation 
of stressful events. Beginning with session seven and continuing 
through session eight, cognitive skills were emphasized. In particular, 
emphasis was placed upon self-instruction, alteration of irrational 
beliefs, and thought stopping. Weekly treatment sessions concluded with 
sessions nine and ten and discussion of overt and covert contracting.
The group therapy condition was designed primarily as an 
alternative treatment condition and secondarily as an attention/placebo 
control condition to control for non-specific factors such as therapist 
attention, group support, and participation in a psychological treatment 
program. The focus was upon the discussion of emotional issues which 
patients had experienced in the past or were currently experiencing.
The format was non-directive and particular recommendations for dealing 
with stress were not made (nor were homework assignments utilized).
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Therapists did not initiate discussions of methods of behavior change 
and when patients initiated such discussions, the therapists did not 
become involved. Rather, the therapists reflected the discussion back 
to group members.
The no treatment condition patients underwent the pretreatment and 
posttreatment assessments concurrently with the treated patients. 
Following the end of the weekly treatment sessions, the control patients 
were offered a relaxation treatment program.
Measures
All dependent measures were obtained at pretreatment and post­
treatment (see Table 7). Primary dependent measures were: (a) the SI,
(Rosenman, 1978) the VSI (Friedman et al., 1981) for the assessment of
3
the TABP , as well as, the JAS (Jenkins et al., 1967), the Framingham 
scale (Haynes et al., 1978), and the Bortner scale (Bortner, 1969), and 
(b) physiological responses, i.e., heart rate (HR), systolic blood 
pressure (SBP), and diastolic blood pressure (DBP), to the stressors. 
Instructions for the Quiz Electrocardiogram (QE) and the cold pressor 
emphasized the challenging nature of the stressors, task difficulty, and 
the need for concentration/will power. Heart rate and blood pressure 
were monitored with an automatic oscillometric device (Model ASD400, 
Automated Screening Devices, Inc., Costa Mesa, CA). During both 
stressors, two measurements of heart rate and blood pressure were made
3 The experimenter was assisted by Edward McCranie, Ph.D., in the 
administration and scoring of the SI. Both Dr. McCranie and the 
experimenter have received training from Drs. Margaret Chesney and Ray 
Rosenman in the SI. In addition, Dr. McCranie will assist in 
determining inter-rater reliability of the Type A assessments. The 
VSI was scored according to VSI criteria (Friedman et al., 1981) and 
SI criteria (Rosenman, 1978).
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during baseline and return to baseline (cessation of the stressor). 
During the stress quiz, blood pressure and HR recordings were made at 
approximately four minute intervals resulting in two recordings during 
the quiz. During the cold pressor, the first recording was made 30 
seconds after hand immersion and proceeded at one minute intervals as 
long as the patient kept his hand immersed. The first return to 
baseline recording was made one minute after completion of the stressor 
and the last recording was made three minutes after completion of the 
stressor.
Instructions for the QE and the cold pressor were presented in a
standardized fashion. The actual QE was presented on a tape
recorder. For the cold pressor task, the patient was instructed to
insert his right hand to -a point two inches above the wrist into an
insulated cooler of ice water. A plastic mesh screen prevented contact 
between the ice and the patient's hand. The water was circulated prior 
to each test. Patients were seated for both procedures.
Secondary dependent measures included: (a) lipoprotein fractions,
i.e., very-low-density lipoprotein (VLDL), low-density lipoprotein 
(LDL), and high-density lipoprotein (HDL), total cholesterol, and 
triglycerides (Blood analyses were performed by the V.A. with lipid 
fractions being determined electrophoretically and cholesterol and 
triglycerides enzymatically.), (b) the state and trait scales of the 
State-Trait Anxiety Inventory (Spielberger, Gorsuch, & Lushene, 1970), 
and (c) the Locke-Wallace Marital Adjustment Scale (Locke & Wallace, 
1959). Ancillary measures included: (a) a weekly checklist of
stressful events and subjective responses to the events (Brantley, 1980, 
see Appendix 5), (b) assessments of program utility, and (c) monitoring
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of weight for any concomitant change which might affect the 
posttreatment lipid results.
Data Analyses
The first analyses to be performed were condition comparisons of
patients' pretreatment characteristics, i.e., age, education, marital
status, employment status, time since unemployment, additional risk
factor status (percent overweight, hypertension, smoking, familial
history of CHD, and blood variables), ejection fraction, severity of
CAD, beta-blockade medication (cf., Krantz et al., 1982), and TABP score
on the SI. One way analyses of variance (ANOVA) were used for the
2
comparisons of continuous variables and X for comparisons of discrete 
variables. Clearly, non-significant differences were desired. Had 
significant differences occured, analysis of covariance would have been 
used in subsequent comparisons with the significantly different measure 
used as the covariate.
The second analysis involved a t-test of the overall score on the 
treatment credibility questionnaire which was completed by participants 
and the rehabilitation staff. Again, a non-significant difference was 
desired.
A final analysis prior to the examination of treatment effects was 
a correlational (Pearson product moment) determination of the 
inter-relationship among the various Type A measurements and CHD, i.e., 
the ejection fraction and index of CAD severity. The relationships 
between the five measures of the TABP and CHD were of particular 
interest because previous evidence is quite contradictory.
Consequently, no hypothesis was posited for this analysis.
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Treatment effects. The efficacy of treatment and the evaluation of 
Hypothesis 1 was examined by a multivariate analysis of variance 
(MANOVA) of the pretreatment to post-treatment change scores on the Type 
A measures by the treatment condition. When a significant effect was 
obtained, as hypothesized, (the time [pretreatment and posttreatment] by 
group [behavorial, supportive, and waiting list] indicated the 
hypothesized effect), ANOVA's and Duncan's multiple range tests were 
performed to assess the magnitude and direction of changes. In these 
analyses, and all other analyses, the alpha level for acceptable 
statistical significance was selected to be p<.05. The reader will 
recall that Hypothesis 1 predicted a significant decrease in SI score 
for the behavioral stress management condition but not for the other two 
conditions.
The analysis of Hypothesis 2, which involved physiological 
responses (SBP, DBP, and HR) to a psychological and a physical stressor, 
used a MANOVA of Treatment Conditions by Time by Periods (baseline, 
stressor, and return to baseline). Baseline and return to baseline 
values were the two values obtained by the BP monitor from each period. 
Similarly, stressor values represented the values obtained during the 
application of the stressors. Univariate analyses were performed if 
significant results were obtained. Hypothesis 2 predicted that the 
behavioral stress management patients would evidence diminished 
physiological reactivity upon post-treatment testing. The group therapy 
and no treatment conditions would not evidence diminished reactivity.
Further analyses examined changes in the other dependent variables 
over the course of treatment, i.e., the additional Type A assessments, 
lipoprotein fractions, cholesterol, triglycerides, the State-Trait
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Anxiety Inventory, the Locke-Wallace Marital Inventory, and the weekly 
stressful events questionnaire. As with the procedure outlined for the 
patient characteristics, one way ANOVAs of change scores were used to 
determine if the treatment condition affected outcome. Due to the 
inter-relationships among the lipid variables a MANOVA was used for the 
lipid analysis. Significant differences were followed by ANOVA's and 
Duncan's multiple range tests, as appropriate.
Results
Reliability of patient assessment
A total of 52 patients were assessed for the Type A behavior
pattern using the VSI. A random sample of 21 of the 52 interviews was
rated for reliability by another trained interviewer using the five
categories of SI classification, i.e., Al, A2, X, B3, and B4. The
reader will recall that a classification as Al represents rather pure
demonstration of Type A behaviors and B4 represents the absence of Type
A behaviors. Categories A2 and B3 represent a predominance of Type A or
Type B characteristics and Type X individuals demonstrate a relatively
even mix of Type A and Type B characteristics. With 15 interviews,
there was no discrepancy in classification and with four interviews
there was a discrepancy of one category. Thus, the overall
4
reliability of interview ratings was 91%. At posttreatment, another
random sample of interviews, 19, was selected for independent rating.
This time, there was no discrepancy with 10 interviews and a discrepancy
of one category with eight interviews yielding an overall reliability of
95%. A sample of the paper and pencil Type A questionnaires was also
independently scored at pre- and posttreatment with 100% reliability.
Behavior pattern assessment
The distributions of patients' scores on the Type A measures, i.e.,
SI, VSI, JAS, Framingham, and Bortner Scales, were highly dependent upon
the particular Type A measure (Murphy, 1980; Murphy, Norman, Lee,
Boineau, & Somes, 1985) as shown in Figures 1, 4, 5, and 6 and Table 9.
4 In training interviewers, Chesney and Rosenman consider a rating
within one classification category as accurate, e.g.; an Al individual 
rated as Al or A2 is accurately rated.
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In Figures 4-6 (Figure 1 is discussed in the preceding Method section), 
the indicated means and standard deviations were obtained in this sample 
of 52 patients (see Table 9). The seven patients excluded from data 
analysis are included in the Figures and the Table to enhance the range 
of scores and comparability with Figure 3. Each bar in the Figures 
constitutes the percentage of patients whose score was within ^ standard 
deviation of scores for the means and respective standard deviations, 
e.g., in Figure 4, 30% of the patients had a score between 163 and 122 
(142.3 ± 20.4) on the Time urgency scale of the VSI. As seen in the 
Figures, scores on all of the Type A measures except the SI showed 
relatively normal distributions. With the SI the patient distribution 
was skewed toward a Type A classification. Scores on the VSI, though 
normally distributed, also indicated a preponderance of Type A behavior, 
as did the Framingham Scale. In contrast, mean scores on the JAS and 
Bortner Scale showed shifts toward a Type B classification, i.e., JAS 
(Type A and factor scales) scores of 0 indicate an even mix of Type A 
and Type B characteristics and mean Bortner scores of 178 were obtained 
from interview defined Type B's (Bortner, 1969). Table 9 also suggests 
that work status had little effect upon Type A scores, i.e., JAS scores 
of employed patients (JAS-C) were comparable to the scores of unemployed 
patients (JAS-N).
To further examine the relationships between the measures of Type A 
behavior, test scores were intercorrelated (see Table 10). In general, 
the interview procedures (SI and VSI) were significantly intercorrelated 
and the paper and pencil measures were significantly intercorrelated.
The Speed and Impatience Scale of the JAS correlated significantly with 
both the interview and paper and pencil measures and the JAS Job
PE
RC
EN
T 
OF
 
PA
TI
EN
TS
£ i9-u-r.e 4 - Patient distribution by the Videotaped Structured Interview.
5 0
4 0
3 0
20
10 I
□  :TIME URGENCY
: COMPETIVENESS & HOSTILITY
TT7\
-2 S D  -1S D  MEAN 1SD 2SD 3SD
\5SD  ^.SSD ^ S D  -KSSD ^ 5 8 0  ± .5SD
VIDEOTAPED STRUCTURED INTERVIEW
PE
RC
EN
T 
OF
 
PA
TI
EN
TS
Figure 5 . Patient Distribution by the Jenkins A ct iv i ty  Survey
50
4 0
30
20
10
222L
-2S D ±.5SD
□
- I S D ^ S D  MEAN ^ S D ISD^SSD
JENKINS ACTIVITY SURVEY
TYPE A
SPEED & IMPATIENCE 
INVOLVEMENT
: HARD-DRIVING & COMPETITIVE
2SD±.5SD ssd^ssd
PE
RC
EN
T 
OF
 
PA
TI
EN
TS
Figure 6 Patient distribution by the Framingham Scale and the Bortner Scale.
5 0
4 0
3 0
20
10
-2 S D
*580
-1 S D
*.5SD
MEAN
* 5 S D
m .
1SD
*.5SD
2SD
* 5 S D
SCALES
□  FRAMINGHAM 
BORTNER
m .
3SD
*.5SD
4SD
* 5 S D
Table 9
Mean Patient Values on Type A Measures
 Measure_____________________________________
VS1: Scale T (Time Urgency)
Scale H (Excess Competitiveness and Hostility) 
Total 
JAS-Na: Type A
Factor S (Speed and Impatience)
Factor J (Involvement)
Factor H (Hard-Driving and Competitive) 
JAS-Ca: Type A
Factor S (Speed and Impatience)
Factor J (Job Involvement)
Factor H (Hard-Driving and Competitive) 
Framingham 
Bortner
SI; (Speech Stylistics: Al=l to B4=5)____________
Negative JAS scores indicate Type B behavior.
n Mean SD Range
52 142.31 40.83 70-240
52 53.17 39.01 0-710
52 195.48 66.58 95-385
45 -2.53 10.15 -19.2-21.5
45 -1.14 10.22 -18.4-22.8
45 -13.04 7.55 -26.6-10.9
45 -.68 9.97 -17.2-27.0
5 -3.06 13.51 -13.3-18.6
5 1.22 7.14 -6.6-7.6
5 -8.88 11.59 -18.4-10.9
5 -1.24 12.46 -15.4-12.8
50 .50 .23 .1-.97
50 180.70 41.59 105-334
52 2.08 1.10 1-5
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Table 10
Intercorrelations among Type A Measures
_______VSI-T VSI-H JAS-A JAS-S JAS-J JAS-H Framingham Bortner
SI .79** .62** .26 .32*
VSI-T .39** .37** .42**
VSI-H .26 .37**
JAS-A .73**
JAS-S
JAS-J
JAS-H
Framingham
23 .20 .23 .26
15 .22 .25 .30*
12 .12 .09 .18
05 .64** .39** .63**
08 .49** .48** .51**
.06 .10 .12
.49** .58**
.41**
* p < .05; ** p < .01.
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Involvement scale failed to demonstrate a significant association with 
any of the other measures. Thus, the two types of assessment 
procedures, interview or paper and pencil, do not seem to demonstrate 
strong agreement based upon correlational analyses. To further examine 
this possibility, the agreement between measures in classifying patients 
as Type A or not Type A was evaluated. Using the SI as the criterion, 
patients were considered Type A if they received a classification of A1 
or A2. Classifications of X, B3, or B4 were considered to be not Type 
A. The remaining Type A measures provide continuous numerical scores 
and patients were dichotomized at the mean score of each measure. For 
purposes of these analyses, patients scoring above the mean were 
considered Type A and patients scoring below the mean were considered 
not to be Type A. Results (see Table 11) indicated that classification 
agreement ranged from a low of 54% on JAS Type A to a high of 84% on VSI 
Time Urgency. The proportion of agreements was tested as being 
significantly different from chance (.5) using a z-test (normal 
approximation of binomial distribution). Agreement with the SI was 
significantly better than chance for the VSI, the Framingham Scale, and 
the Bortner Scale.
Type A and CHD
A correlational analysis of scores of the various Type A measures 
and the two measures of heart disease (see Table 12) indicated that the 
behavior pattern was not significantly related to either the severity of 
artery disease or the ejection fraction (Murphy et al., 1985). In fact, 
correlations were sometimes negative and, thereby, suggesting that Type 
A behavior in this patient sample was associated with reduced arterial 
occlusion and enhanced left ventricular functioning. However,
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Table 11
Agreement in Behavior Pattern Classification
% AgreementMeasure3
Agreement with SI Classification 
A (n=32)b Not A (n=20)C
VSI-T 23 20 83%**
VSI-H 27 27 65%*
JAS-Ad 16 11 54%
JAS-Sd 19 11 60%
JAS-Jd 19 10 58%
JAS-Hd 17 14 62%
Framinghamd 21 12 66%*
Bortnerd 19 14 66%*
a  b
Sample divided at mean patient score. Types Al and A2 and above mean 
score of second measure. Types X, B3 and B4 and below mean score of 
second measure. ^Completed by only 50 patients due to one death (Type 
X) and one dropout (Type B3).
*p<.05; **p<.01.
Table 12
Correlation Coefficients of Type A Measures with CAD Severity
TYPE A MEASURE ARTERY DISEASE EJECTION FRACTION
SI .11 -.04
VSI: SCALE T -.07 .01
SCALE H -.06 -.08
JAS: TYPE A .18 -.08
FACTOR S .19 .02
FACTOR J -.15 .04
FACTOR H .08 .09
FRAMINGHAM -.01 -.13
BORTNER .03 -.09
ALL VALUES NONSIGNIFICANT.
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irrespective of the Type A measure, the behavior pattern bore little
relationship to CHD and could, at best, explain only 3.6% of the
variance in CAD (JAS Factor S) and 1.7% of the variance in ejection
fractions (Framingham Scale).
Pretreatment patient characteristics
Values for patient characteristics by treatment condition at
pretreatment are shown in Table 6 (see Method). Analyses of variance
2
for continuous variables and X for discrete variables indicated that 
the groups were comparable on all variables. Consequently, covariates 
were not introduced in the statistical analyses.
Experimental group comparisons
Prior to analyzing changes during treatment, groups were compared 
for the comparability of treatment credibility (see Appendix 4). First, 
the comparison of the two active treatment conditions was 
nonsignificant, IT (1,28) = 1.41; £=.24. Next, spouse perceptions of 
treatment efficacy, including spouses of patients in the no treatment 
condition, were compared (see Appendix ) and again a nonsignificant 
effect was obtained, 1? (2,37) = 2.20; p=.124. Finally, the perceptions 
of the professional members of the rehabilitation team, physician, 
physicians assistant, psychologist, social worker, exercise 
physiologist, and dietitian, were assessed through video taped segments 
of the second and final sessions (see Appendix 4). The team members saw 
both groups as equally credible, F(l,10)= 2.24; £=.166.
Attendance. Attendance at the sessions was variable among the 
patients. During the treatment period, there were two deaths; one each 
from the behavioral and waiting list conditions. One death was due to 
cerebral hemorrhage, secondary to atherosclerosis, and the other was due
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to cancer. Patients in the supportive condition attended approximately 
one more session than those patients in the behavioral condition but 
this difference was not significant, £>.05. The mean number of sessions 
attended by the supportive and behavioral conditions were 8.2 and 6.9, 
respectively.
Type A Assessments. A multivariate analysis of variance, MANOVA, 
using the Hotelling-Lawley trace (used with all MANOVA's unless 
otherwise stated) indicated that the time (pretest to posttest) by group 
(behavioral, supportive, or waiting list) interaction was not 
statistically significant, £(18,60) = 1.02, j>£.51. Thus, the effect of 
group assignment and treatment did not demonstrably alter Type A 
behavior. Similarly, the overall group effect was not statistically 
significant, £(18,66) = .72, £=.77. However, the effect of time 
(pretest to posttest) did show a significant effect, £(9,31) = 3.05, £= 
.01. Subsequent analyses of variance, ANOVA, indicated significant 
change over time as assessed by the Framingham Scale, F(l,39)=7.65, 
£=.009, and the Bortner Scale, £(1,39)=4.37, £=.043, as well as the 
Structured Interview, £(1,39)=6.71, £=.013. As seen in Table 13, the 
changes in Type A scores were modest and, at times, showed increases 
rather than decreases in Type A score. For example, with the VSI scores 
on the Time Urgency Scale increased in both of the active treatment 
conditions. In contrast, the VSI-T scores of the Waiting List condition 
decreased from pre- to posttreatment. However, Type A scores generally 
decreased with the exception of JAS scores, but the decreases of the 
Waiting List conditions approximated the decreases of the treatment 
conditions.
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Table 13
Mean Scores on Type A Measures
Condition
Behavioral Supportive Waiting List
Measure Pre Post Pre Post Pre Post
JAS-Aa -2.05 -.63 -5.49 -3.85 -.42 -.42
JAS-SI -1.29 -.58 -4.11 -3.45 1.87 3.12
JAS-1 -11.79 -10.04 -10.85 -12.91 -14.96 -12.05
JAS-HD -4.10 -.35 -.21 -.17 1.20 -1.32
Framingham^ .44 .39 .47 .37 .56 .45
Bortnerb 186.86 180.00 173.88 154.00 184.80 178.64
VSI-T 142.67 147.50 139.24 142.33 151.67 144.64
VSI-H 61.67 59.29 52.95 49.00 50.00 59.29
sib 4.07 3.86 4.06 3.74 4.14 3.72
Note. Higher scores indicate a higher Type A score, 
ci bNegative JAS scores indicate Type B behavior. Significant reductions 
for all patients which were not affected by treatment condition.
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Quiz Electrocardiogram. MANOVA's were again used to analyze the 
QE, see Figures 7, 8, and 9, and again results showed nonsignificant 
differences among conditions over the course of treatment, IT (36,40) = .89, 
£=.63, and for the overall group effect, IT=(36,53) = .89, £=.64. Unlike 
the Type A assessment, however, change from pretreatment to 
posttreatment was also nonsignificant, I?(18,21)=1.64, £=.14. Therefore, 
treatment had little effect on the cardiovascular response to the QE. 
This result is generally apparent from the corresponding figures which 
show that all three variables, SBP, DBP, and HR, demonstrated modest 
decrements from pre- to posttreatment which were quite similar among the 
three conditions.
Considering SBP (Figure 7), the Behavioral condition demonstrated 
the greatest decrements during the quiz, 13 mmHg and 18 mmllg during the 
two quiz measurements, but these changes were not statistically 
different from the changes in the other two conditions. As shown in 
Figure 8, DBP decrements were quite similar across the three conditions, 
e.g., mean decreases of 7.3 mmHg, 8.1 mmHg, and 6.4 mmHg in the 
Behavioral, Supportive, and Waiting List conditions, respectively, 
during the first QE measurement. In contrast with the BP changes, HR 
(Figure 9) showed very little reactivity to either the QE or 
posttreatment assessment, i.e., HR generally varied from 1-3 bpm.
Cold pressor. The results of the cold pressor assessment are 
illustrated in Figures 10, 11, and 12. As can be seen in the Figures, 
the cold pressor was effective in provoking a hemodynamic response. 
Across all patients, the mean pretreatment response from the end of 
baseline (second measurement) to the first task response (third 
measurement) was 20.3 mmHg for SBP, 14.6 mmHg for DBP, and 3.7 bpm for
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Figure 7. Systolic blood pressure responses to the QE.
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Figure 8. Diastolic blood pressure responses to the QE.
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Figure 9. Heart rate responses to the QE.
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HR. However, posttreatment values during this same time period from the 
end of baseline to the first cold pressor measurement, i.e., SBP and DBP 
increases of 21.2 mmHg and 13.0 mmHg and a HR increase of 3.2 bpm, were 
very similar to the pretreatment responses. A MANOVA could not be 
performed upon the cold pressor results due to missing values, i.e., the 
final data set included only 17 observations. The reduced subject 
number is due to subjects removing their hands from the water prior to 
automatic termination at five minutes. Therefore, ANOVA’s were utilized 
to assess the time by group interaction at each measurement point. None 
of these analyses attained statistical significance though the third HR 
during hand immersion approached significance, £=.056. However, 
considering the number of analyses performed little, if any, importance 
should be attached to this result. The effect of time was also 
consistently nonsignificant, all £'s>.05. As with the stress quiz, the 
figures of SBP, DBP, and HR show that little change occurred in the 
response to the cold pressor from pre- to posttreatment assessment and 
that not participating in treatment was as effective as participating in 
treatment in producing the response changes which did occur.
Lipids. Lipid changes over the course of the treatment period are 
shown in Table 14. As discussed with previous outcome variables, the 
MANOVA of the time x group interaction failed to show that lipid changes 
were differentially affected by the treatment conditions, J7(10,48) =
.15, £=.99. Again, the MANOVA for time of assessment was significant, 
F(5,25)=6.56, £=.0005. The subsequent ANOVA's for the particular lipids 
indicated that the LDL change and VLDL change were both significant at 
posttreatment, F(l,29)=8.49, £=.007 and ]?(1,29)=11.02, £=.002, 
respectively. However, as seen in Table 14, the VLDL change was a
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Figure 10. Systolic blood pressure responses to the cold pressor. 
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Figure 11. Diastolic blood pressure responses to the cold pressor.
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Figure 12, Heart rate responses to the cold pressor.
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Table 14
Mean Lipid Levels by Treatment Condition
Condition
Behavioral Supportive No Treatment
Pre Post Pre Post Pre Post
Cholesterol3 197.9 204.4 227.4 236.0 195.5 204.8
Triglycerides 335.9 324.3 227.8 347.9 233.2 231.2
HDLb 16.9 17.4 16.7 17.4 18.6 19.5
LDLb 61.7 65.0 65.1 67.1 64.4 69.7
VLDLb 21.3 19.3 18.2 17.1 17.7 12.4
3. bmg/dl; % cholesterol (to convert percentages to mg/dl, multiply the 
cholesterol value by the value of the lipoprotein fraction).
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decrease, whereas the LDL change was an increase in value. Thus the 
treatment program had no demonstrable effect upon the patients' lipid 
profiles.
Additional outcome variables. ANOVA's of change scores (posttest 
minus pretest) were used to determine if the three conditions showed 
differences on these measures. First, changes in marital satisfaction, 
as measured by the Locke-Wallace Inventory, were not significantly 
different, F_(2,36) = . 22, £=.80, despite changes which were two to three 
times greater in the two treatment conditions. The mean respective 
changes for the behavioral, supportive, and waiting list conditions were 
6.1, 7.5, and 2.6. Similarly, changes on the Spielberger State-Trait 
Anxiety Inventory failed to demonstrate significant differences. Mean 
group changes on State anxiety were -2.9, 2.0 (an increase), and .5 (an
increase) for the behavioral, supportive, and waiting list,
respectively, F(2,40)=.57, £=.57. The corresponding Trait changes were 
-3.2, .1 (an increase), and -2.1, F_(2,40)= .54, £=.59. The Holmes Rahe 
Inventory of Life Events also showed nonsignificant changes,
]?(2,40)=.80, £=.45. All groups reported increases in stressful life 
events with means of 46.4, 265.3, and 376.9 for the behavioral, 
supportive, and waiting list conditions, respectively. Finally, weight 
changes did not differ reliably among conditions, F^2,41)=.58, £=.57.
The mean weight changes (in pounds) for the behavioral, supportive, and 
waiting list conditions were .7, 2.4, and 1.5 (all increases).
The mean weekly stress ratings which had a range from 0 (no stress)
to 10 (stress equal to most stressful week ever had) are shown in Table 
15. As seen in the table, stress ratings were within low and tolerable 
limits and group differences were nonsignificant through the sixth week.
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In 10 of the 11 assessment periods, the behavioral condition reported 
less stress than the supportive condition. This difference was 
significant during the seventh and eighth weeks. At the final session, 
both treatment groups reported significantly less stress than the no 
treatment waiting list condition.
Table 15
Mean Weekly Stress Rating by Treatment Condition^
Week__________ Behavioral_____Supportive____ No treatment F(df),p
Pretreatment 2.85 3.86 4.40 NS
1 2.33 3.08 N/A NS
2 3.44 3.00 N/A NS
3 2.33 3.23 N/A NS
4 2.67 2.86 N/A NS
5 2.80 3.54 N/A NS
6 3.00 3.17 N/A NS
7 2.1 la 3.17b N/A 5.30(1,19),.03
8 2.00a 3.38b N/A 5.61(1,12),.04
9 1.83 3.00 N/A NS
10 2.50a 2.88a 3.93b 4.24(2,39),.02
^Different superscripts denote significant, £<.05, group differences
(Duncan's Multiple Range Test)
Discussion
Overall, the results of this investigation did not support the 
hypotheses that a behavioral stress management program would ameliorate 
Type A behavior and cardiovascular reactivity in this sample of cardiac 
rehabilitation patients. In fact, the magnitude of the changes which 
did occur during the treatment were generally similar in the no 
treatment control group and in the two active treatment conditions. 
However, results may not have been due to limitations of the behavioral 
program. Rather, patients in the supportive and waiting list conditions 
may have benefited from their participation in this investigation and, 
more importantly, previous and concurrent participation in the 
rehabilitation program. These ideas are developed in the following 
discussion.
Change in the Behavior Pattern
Previous investigations (see Introduction) have generally reported 
successful Type A interventions. In the Recurrent Coronary Prevention 
Project's (RCPP) latest report (Friedman et al., 1984), 44% of patients 
in the Type A behavioral counseling condition evidenced a reduction in 
Type A behavior at the end of three years compared to 25% of the 
patients only receiving cardiologic counseling. More importantly, the 
Type A counseling condition experienced a three year cumulative cardiac 
recurrence rate of 7.2%. The recurrence rate was 13% in the cardiologic 
counseling condition and the difference between the two conditions was 
statistically significant, £<.005.
Treatment Considerations. The RCPP results may point up a 
limitation in the present study, i.e., a treatment program without
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follow-up. A lengthy follow-up might have demonstrated treatment 
effects. While the hypothesis that treatment efficacy could be 
demonstrated over a prolonged period is tantalizing, this hypothesis 
does not seem tenable. First, RCPP reports indicated that changes in 
the TABP were noted prior to changes in morbidity, i.e., significant 
differences in Type A change were apparent before recurrence rates were 
significantly different (Powell et al., 1984; Thoresen, Friedman,
Powell, Gill, & Ulmer, 1985). Patients showing high TABP change (a 
standard deviation or more on the VSI score) during the first year had 
one fourth the cardiac recurrence rate during the second and third years 
of patients not showing this degree of Type A change (1.7% vs 8.6%, 
p<.001). Of these high change patients, 91% were in the behavioral 
condition (Thoresen et al., 1985). Thus, the differences between the 
RCPP results and the present results may be explicable in terms of 
differences in the treatment programs. The primary difference seems to 
involve the duration of treatment and the timing of data analysis. The 
RCPP involved a one year treatment program after which participants were 
enrolled in an on-going follow-up program. In addition, treatment 
results were not analyzed prior to the one year conclusion of treatment. 
Therefore, comparisons with the RCPP are somewhat inappropriate as 
changes which occurred during the initial three to four month 
(comparable to the present study) period are unknown.
However, short-term studies, though often not in patient samples, 
(e.g., Blumenthal et al., 1980; Levenkron et al., 1983; Lobitz,
Brammell, Stoll, & Niccoli, 1983; Suinn & Bloom, 1978) have demonstrated 
pre- to posttreatment changes in the TABP. Two recent reports of 
patient interventions (Baer et al., 1985; Razin, 1984) have also
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reported TABP changes during a brief treatment period. Unfortunately, 
these studies are marred by the methodological problems of the studies 
in Table 4, i.e., different pre to posttreatment assessment of the TABP 
(Baer et al., 1985) and use of a single group pre-post design (Razin, 
1984). None-the-less, the pattern of beneficial TABP change is fairly 
consistent. These studies used treatment protocols quite similar to the 
present study and why the discrepancy between the present results and 
previous investigations occurred does not seem to be explicable in terms 
of the treatment protocol.
Another possibility may be that the group leaders were ineffective. 
However, the program was rated as logical and useful by both the program 
participants and the professional staff of the rehabilitation program. 
While the efficacy of the group leaders was not directly rated, 
ineffective or incapable leadership would, presumably, have been 
reflected in the credibility questionnaire and this was not the case. 
Therefore differences in treatment procedures do not seem to be an 
adequate explanation of why significant changes in the TABP were not 
observed.
Assessment considerations. Another possible explanation for the 
lack of beneficial TABP change concerns the assessment of the behavior 
pattern, i.e., perhaps Type A was assessed inadequately or inaccurately. 
This explanation, also, appears to be inadequate for several reasons. 
First, the interviews were conducted by an interviewer trained by 
Rosenman and associates and the behavioral ratings of the interviewer 
were reliable with the ratings of a second interviewer who had also been 
trained by Rosenman. Second, the behavior pattern was assessed using 
several measures of the behavior pattern which should have provided a
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rather sensitive test for Type A change. While others (e.g., Byrne, 
Rosenman, Schiller, & Chesney, 1985; Chesney, Black, Chadwick, & 
Rosenman, 1981) have demonstrated consistent significant 
intercorrelations among Type A measures, this study did not 
(see Table 10). However, these studies employed substantially larger 
samples, N=468 (Byrne et al.) and N=384 (Chesney et al.), than the 
present study. More importantly, the general pattern, i.e., interview 
procedures significantly intercorrelated and self-report questionnaires 
significantly intercorrelated, and magnitude, i.e., .3 to .8, of the 
significant correlations in this study are similar to those obtained in 
previous studies (Byrne et al. 1985; Chesney et al., 1981; Powell et 
al., 1984). Thus inadequate assessment of the behavior pattern does not 
seem to be a plausible explanation for the lack of positive results in 
this study.
Assessment procedures may, however, offer a partial explanation.
The reader will recall that the VSI was used as the basis for random 
assignment of patients. Since Friedman's original exposition of the VSI 
(Friedman et al., 1981), scoring procedures for the VSI have changed 
though not drastically (cf Powell et al., 1984). In retrospect, 
assignment of patients should have been based upon the SI. However, the 
SI and VSI were significantly correlated and the absence of a perfect 
correlation can not fully explain the present results.
Type A - CAD considerations. A third explanation for the lack of 
positive treatment outcome involves the subjects and the relationship 
between their Type A behavior and their heart disease. The Type A - CAD 
relationship had shown a nonsignificant negative association (see Table 
12) while the majority of previous studies had shown significant
87
positive associations. Therefore, previous investigations of the Type A 
- CAD relationship were reexamined and the methods of determining CAD 
severity were determined (see Table 16; Murphy, Norman, & Somes, 1985). 
These methods illustrate a wide diversity of CAD assessment to which 
must be added the method used in this study. Subsequently, the 
severity of CAD of each patient was recalculated with each scoring 
system and was correlated with the Type A scores which had been 
obtained at the pretreatment assessment. These results (see Table 17) 
demonstrated that Type A behavior was not associated with more severe 
CAD. In fact, when the behavior pattern correlated in a significant or 
marginally significant manner, the relationship was an inverse 
relationship, i.e., high TABP and low CAD or low TABP, i.e., Type B 
behavior, and high CAD.
This evidence, suggesting that the TABP may not be pathogenetic in 
this patient sample, may be explicable due to the retrospective nature 
of the investigation, medication usage, or the age of the subjects. As 
indicated, patients had been catheterized prior to the Type A 
assessment, a mean of 3.2 years prior to Type A assessment. However,
CAD is most often a progressive disease even in patent bypass grafts 
(Campeau et al., 1984) , CAD regression in humans has been documented 
infrequently (Hammond, 1983), and the contribution of the behavior 
pattern to progression or nonprogression has not been reliably 
documented (Krantz et al. , 1979). Thus, there is little reason to 
believe that sufficient regression had occurred in patients to produce 
the reported negative correlations. Medication usage, also seems 
implausible despite reports that beta blockade ameliorates the 
exhibition of Type A behavior (Schmieder, Friedrich, Neus, Rudel, & Von
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Table 16
Scoring Systems Used in Assessing the Type A/CAD Relationship
Studies Number of Segments' Disease Definition 
(occlusion:score)
1. Friedman et al. (1968) 2(RCA,LCA)
2. Frank et al. (1978) 4(RCA,LAC,LAD,CFX)
Dimsdale et al. (1979a,b)
3. Williams et al. (1980) 4(RCA,LCA,LAD,CFX)
Zyzanski et al. (1976)
4. Dembroski et al. (1985) 4(RCA,LCA,LAD,CFX)
5. Blumentha1 et al. (1978) 4(RCA,LCA,LAD,CFX) 
Dembroski et al. (1985)
Krantz et al. (1981)
6. Zyzanski et al. (1976) 4(RCA,LCA,LAD,CFX)
Dimsdale et al (1978)
Scherwitz et al. (1983)
7. Krantz et al. (1979)
8. Bass (1984)
4(RCA,LCA,LAD,CFX) 
4(RCA,LCA,LAD,CFX)
9. Kornitzer et al. (1982) 4(RCA,LCA,LAD,CFX)
0:0; <25%:1; 25%-<50%:2; 
50%-<75%:3; 75%-99%; 100%:5 
0-50%:0; >50%:1
0-74%:0; >75%:1
0-75%:0; >75%:1
0:0; <75%:1; 75%-99%:2;
100%:3
0-<50%:0; >50%:1
10. Dimsdale et al. (1981) 6(LAD:3;CFX:2;RCA:1)
11. Scherwitz et al. (1983) 9 (?)
0-69%:0; >70%:1 
Grpl:0; Grp2:<50%; Grp3:50% 
0:0; <50%:1; 50%:2; 
several of 50% or one 
50%-<90%:3; 90%-<100%:4; 
100%:5
0-70%:0; >70%:2
0:0; <50%:1; 50%-74%:2;
75%-100%:3
RCA: right coronary artery, LCA: left coronary artery, LAD: left anterior
descending artery, CFX: circumflex artery.
Table 17
Correlations among Type A measures and CAD scoring systems.
Type A measure 1 2 3
Scoring System 
4 5 6 7 8 9 10
SI -.19 -.22 -.23* -.26* -.26* -.25* -.21 -.12 -.26* -28**
VSI: Scale T -.06 -.18 -.17 -.21 -.20 -.18 -.17 -.02 -.22 -.21
Scale H -.19 -.17 -.16 -.09 -.24* -. 29** -.14 -.12 -.21 -.17
JAS: Type A .05 .04 .02 -.04 .09 .07 .02 .17 .06 -.17
Factor S .14 .11 .13 .05 .09 .06 .07 .09 .06 -.07
Factor J - . o i b -.09 0.07 .03 i
V0O•1 .11 -.07 -.07 -.04 -.12
Factor 11 .06 -.01 -.02 .-3 -.10 .12 -.03 .16
o«1 -.28*C
Framingham .08 .08 .06 .16 -.02 .05 .04 .08 .05 -.15
Bortner .05 .03 .03 .04 . 0 1 .01 .01 .08 - . o i b -.17
Scoring systems correspond to the systems identified in Table 1, e.g., scoring system 1
is the system used by Friedman et al. [5] (method used by Scherwitz et al. [17] to divide
b cthe coronary arteries could not be determined). Value actually < .01. Identical
correlations at different £ values are indicative of different degrees of freedom.
*p<.10; **p<.05.
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Eiff, 1983). In the present sample, 92% of the patients were receiving 
beta blockers. Nonetheless, the SI showed a preponderance of Type A 
behavior with proportions of patients in each category similar to other 
prospective reports (e.g., Dembroski, MacDougall, Williams, Haney, & 
Blumenthal, 1985; MacDougall, Dembroski, Dimsdale, & Hackett, 1985) in 
which medication usage is not likely to have been as widespread. 
Correspondingly, VSI scores were similar to those reported by Friedman 
et al. (1981). Therefore, medication usage seems to be an inadequate 
explanation.
Finally, the subjects' ages may provide the best explanation for 
the negative correlations. While age failed to significantly correlate 
with any of the CAD severity scores, a significant correlation with the 
JAS Type A score was obtained, r=-.32, £=.023. Our subjects were 
older, mean age of 60.1, than subjects in previous studies, e.g., mean 
ages of 47 years (Blumenthal et al., 1978) and 50 (Dimsdale et al., 
1981) and reports from the WCGS (Rosenman et al., 1967; 1976) and the 
Framingham Heart Study (Haynes et al., 1980) have indicated that the 
significance of the Type A behavior pattern is reduced with advancing 
age both in terms of initial and recurrent coronary events. Based upon 
a review of over 2100 angiography patients, Williams (1985) reported 
that among patients younger than 45, Type A's had more severe CAD than 
Type B's. Among patients 55 and older, the Type B's, rather than the 
Type A's, had more severe CAD. Corroborative findings have been 
reported by Blumenthal and Herman (1985). In particular, subjects 
younger than 40 years of age perceived themselves as becoming more Type 
A. In contrast, 40 to 50 year-olds viewed their Type A behavior as 
unchanging and subjects older than 50 saw themselves as experiencing
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significant reductions in their Type A behavior. Similarly, the 
subjects in the present study may have been particularly hardy Type A's 
or have passed a "critical" age at which the behavior pattern had a 
decreasing pathogenetic effect. The hypothesis that older Type A's are 
hardier than younger Type A's has some support in the research of 
Kobasa (Kobasa, Maddi, & Zola, 1983). This research has demonstrated 
that hardiness is inversely related to illness and that Type A's high 
in hardiness are less susceptible to illness than Type A's who are low 
in hardiness. Friedman, Hall, and Harris (1985) have also suggested 
that there may be two categories of Type A individuals which were 
differentiated on the basis of nonverbal expressiveness. Using 
subjects from the MRFIT study, one Type A group was found to be 
healthy, talkative, and charismatic while the second Type A group was 
found to be repressed, tense, and illness-prone.
Another subject variable that may be important is the period of 
time that had passed since the patient's cardiovascular events. As 
shown in Table 9, the mean number of years that the patients had been 
enrolled in the rehab program ranged from 3.5 to 4.6 years across the 
three conditions. This prolonged period of participation far exceeds 
that of other studies and may suggest that this particular patient 
sample was not an ideal sample. Friedman (1979) suggested that post-MI 
patients were good condidates for TABP interventions because they find 
time to review their lives during recovery and experience frightening 
symptoms. The patients in this sample had probably had more than 
adequate time to review their lives and become comfortable with their 
medical status. Studies investigating psychological recovery from an 
MI (Doehrman, 1977 for a review) have generally shown that the extent
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of distress declines as time since the incident increases. Subjects 
had also become comfortable with their lifestyle, e.g., 40 of the 45 
patients were retired and had been so for, on average, over six years 
and had no intention of returning to work. Furthermore, 33 of the 
patients regularly experienced coronary symptoms, e.g., angina, 
shortness of breath, tachycardia, and were rarely fearful of these 
symptoms. Therefore, the motivation to change may not have been as 
great as with the patients in other studies.
A perusal of Table 4 indicates that investigators often required 
patients to be less than a specified age and to have experienced their 
MI (generally the first MI) within a certain time frame before 
commencing treatment. Patients in this study almost always exceeded 
both of these parameters. The potential role of age in affecting 
treatment outcome can also be seen in the mean ages of subjects listed 
in Table 5. Ages have generally been between early 40's and early 50's 
which makes the subjects in previous investigations 10 to 20 years 
younger than the subjects in the present investigation.
Concurrent therapy (exercise) considerations. A final 
consideration in explaining the lack of demonstrable changes in the 
TABP concerns the background upon which the treatment program had been 
superimposed. All of the patients were enrolled in an on-going 
exercise rehabilitation program designed for the recovery of 
cardiovascular functioning. The evidence supporting the benefits of 
exercise in the prevention of cardiovascular disease (e.g., Haskell, 
1984; Paffenberger, Hyde, Wing, & Steinmetz, 1984) and the 
rehabilitation of cardiovascular functioning (e.g., Fletcher, 1984; 
Shepherd, 1983) is extensive and beyond the scope of this paper. A
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recent review (Roman, 1985) concluded that the short-term results of 
exercise programs were conclusive and excellent and that the long-term 
results were suggestive but not conclusive. Reviews of the psychologic 
effects of exercise (e.g., Folkins & Sime, 1981; Goff & Dimsdale, 1985; 
Taylor, Sallis, & Needle, 1985) have concluded that while methodologic 
problems exist and mechanisms of action have yet to be clearly 
elucidated, psychologic benefits accrue to exercisers. Thus there 
seems to be good reasons for over 700 cardiac rehabilitation programs 
which are primarily exercise oriented across the United States (Stoner,
1983). The beneficial effects of exercise upon cardiovascular risk 
factors, e.g., blood pressure, cholesterol, HDL, triglycerides, and 
weight, have been repeatedly demonstrated.
More germaine to the present discussion is the Blumenthal et al. 
(1980) report showing beneficial changes in Type A behavior during an 
aerobic conditioning program. Recently, Lobitz et al. (1983) also 
demonstrated TABP decreases with aerobic exercise. In both studies, 
subjects were not patients and TABP change was defined by the JAS. 
Lobitz et al. also reported that the exercise program was superior to 
an anxiety management condition based upon Suinn's (1975) work. 
Additional exercise studies which have not directly assessed the 
behavior pattern have reported positive changes in components of the 
behavior pattern, e.g., belligerence, negativism, and suspiciousness 
(Stern & Cleary, 1981) and anger (Berger & Owen, 1983). While not all 
studies have reported improvement in Type A behavior (e.g., Jasnoski, 
Holmes, Solomon, & Aguiar, 1982; Rejeski, Morley, & Miller, 1984), the 
overall evidence suggests that aerobic exercise has beneficial effects 
on the behavior pattern. While this possibility can not be directly
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determined, the reader will recall that despite their notable artery 
disease, the mean ejection fraction of 63.6%, was within normal limits 
of 67% ± 8% (Dodge & Sandler, 1974). As the outcome of an infarction 
is independently determined by ischemic damage, as well as left 
ventricular dysfunction (Bigger, Coromilas, Weld, Reiffel, & Rolnitzky, 
1984), the normal ventricular functioning may have allowed patients to 
more fully participate in the exercise portion of the rehabilitation 
program, as well as exercising at home. Further, patients were 
compliant with the exercise program and given their cardiovascular 
condition were, perhaps, doing as well as they could. Thus, exercise 
may have had a palliative effect upon CAD progression and a remediative 
effect upon Type A reduction.
In summary, the lack of demonstrable changes in Type A behavior 
during the course of the present study may be explicable. The foremost 
reason would seem to be the patients' ages, i.e., these patients were 
hardy or sociable Type A's who may have passed a critical age at which 
the behavior pattern began to lose its pathophysiological significance. 
Another significant consideration is the patients' prolonged 
participation in an exercise oriented cardiac rehabilitation program 
which may have moderated their Type A behavior. For these reasons, any 
type of TABP intervention might not have been able to demonstrate 
significant efficacy.
Change in Cardiovascular Reactivity
The second shortcoming of the present study is the failure to 
reduce cardiovascular (CV) reactivity. Comparisons with investigations 
discussed in the introduction are difficult for only one study utilized 
a stressor as part of the treatment evaluation. In that study
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(Levenkron et al., 1983) of nonpatient Type A's, the mean pre- to 
posttreatment reductions in SBP (5.6 mmHg) and DBP (4.4 mmHg) were 
significant but were not related to the treatment conditions. Reduc­
tions in HR were neither significant nor reported. Therefore, to 
compare the CV responses of this study's patients to the two stressors, 
previous investigations using these stressors were reviewed to 
determine the magnitude of CV responses.
Unfortunately, the QE has not received much usage as a stressor.
In the original study by Schiffer et al. (1976), HR changes were in the 
order of 10 BPM and BP changes were in the order of 7 mmHg and 22 mmHg 
for DBP and SBP, respectively. More recently, Sime et al. (1980) 
investigated CV responses in post-MI patients and reported changes of a 
similar magnitude. Using an abbreviated history quiz, Dembroski, 
MacDougall, and Lushene (1979) reported SBP response of approximately 
24 mmHg and DBP responses of 11 mmHg in another post-MI sample. Thus, 
while little research with the QE has been undertaken in CAD patients, 
the magnitude of the response is fairly consistent. With the cardiac 
rehabilitation patients, the mean CV reactivity was substantially less 
than in these studies. Mean changes (mean of two baseline values minus 
mean of two quiz values) across all subjects at pretreatment in HR,
SBP, and DBP were .9 BPM, 14.7 mmHg, and 7.7 mmHg, respectively. Given 
this level of CV change, especially for HR, the likelihood of 
substantial CV reduction as a result of treatment seems remote, at 
best. In fact the posttreatment assessment did demonstrate modest mean 
CV reductions of 5.7 mmHg for SBP, 3.3 mmHg for DBP, and .5 BPM for HR 
for all participants. As changes were nonsignificantly different 
across the three conditions, the reductions may simply represent
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habituation to the stressor. However, another possibility is that the 
reductions were merely random error due to the use of an unreliable 
stressor. A recent study by Williamson, Waters, Bernard, Faulstich, 
and Blouin (1985) with college students indicated that the quiz was 
unreliable across a two week period. While a comparable investigation 
with CAD patients has not been conducted, the correlations between pre- 
and posttreatment assessments in the waiting list condition (n=14) were 
consistently significant and are shown in Table 18. In fact, CV 
responses during the quiz were more reliable than during baseline or 
recovery and the magnitude of the correlations is quite satisfactory 
(cf. Krantz & Manuck, 1984). Thus, in the present study, the 
reliability of the stress quiz is not a satisfactory explanation for 
the nonsignificant changes in CV reactivity during treatment. However, 
a more likely explanation lies in the patients’ medication regimens.
The role of medication in attenuating CV reactivity is discussed 
following the discussion of cold pressor reactivity.
The second stressor, the cold pressor (Hines & Brown, 1936), has 
received more usage than the QE and for comprehensive reviews the 
reader is referred to Lovallo (1975) and Ruddel, McKinney, Buell, 
Blumsohn, and Eliot (1984). In their discussion of reliability, Ruddel 
et al. concluded that the CV pattern to the cold pressor remains stable 
if the repeat tests are performed in the same way on each occasion and 
that an untreated control group should also undergo the repeated 
testing. As this study adhered to these recommendations, the results 
may be viewed with some confidence. However, as with the QE, the cold 
pressor demonstrated nonsignificant changes due to treatment.
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Table 18
Mean Correlations between Pre- and Posttreatment QE for the Waiting 
List Control Group
___________________ Baseline________________ Quiz__________ Recovery
SBP .73** .91** .66*
DBP .67** .73** .59*
HR .78** .89** .79**
*p<.05; **p<.01.
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As with the QE, the magnitude of CV reactivity to the cold pressor 
was determined in previous studies using CAD patients as subjects. In 
general, the CV response to the cold pressor has been in the range of 
25-50 mmHg for SBP and approximately 50% of the SBP response for the 
DBP response, i.e., 15-35 mmHg which is accompanied by a HR change of 
10 BPM (Palmer, Ziegler, & Lake, 1978; Voudoukis, 1971; Wasserman et 
al., 1983; Waters et al., 1983). This HR response is equivalent to 
that of healthy subjects while the BP response is greater than the BP 
response of healthy subjects (Ruddel et al., 1984). The Voudoukis 
study is also pertinent for the comparison of patients with CAD and 
hypertension to patients with only CAD. In this study, the BP 
response of patients with hypertension superimposed upon heart disease 
was reported to be 45% greater than in those patients with only heart 
disease. Correspondingly, the CV response of older subjects (40+ 
years) has been reported to be significantly greater than that of 
subjects younger than 40 years of age (Palmer et al., 1978). Thus, 
subjects in the present study might have been expected to demonstrate 
dramatic increases in HR and BP due to their age and BP status (29 of 
45 patients with hypertension).
However, the patients' CV responses to the cold pressor were 
substantially muted. Specifically, the average HR response across all 
patients was only .7 BPM. Blood pressure responses were greater, mean 
SBP response of 20.8 mmHg and mean DBP response of 10.2 mmHg, but less 
than the BP responses reported in previous investigations. As might be 
expected, the difference (reduction) at posttreatment was also muted. 
The mean changes were decreases of .1 BPM, 3.4 mmHg for SBP, and an 
increase of .6 mmHg for DBP. Again the reduced magnitude of CV
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response likely reflects the effects of medication which may have 
precluded the demonstration of treatment efficacy.
Concurrent therapy (medication) considerations. As mentioned in 
the discussion of CV reactivity to the stress quiz and the cold 
pressor, patients demonstrated blunted HR and BP responses. The 
patients1 medications, especially beta blockers, were probably 
responsible for these effects. Beta blockers were introduced 
approximately two decades ago and now are widely used in the treatment 
of cardiovascular disorders. Beta blockers primarily compete with 
epinephrine and norepinephrine at the adrenergic receptors. As a 
consequence, their effects are greatest during the activation of the 
sympathetic nervous system, i.e., during times of either physical or 
psychological stress. F.or further discussion of the mechanisms of beta 
blockade, the reader is referred to a cogent review by Durel, Krantz, 
Eisold, and Lazar (1985) or more medically oriented reviews by Nies and 
Shand (1975) and Frolich, Dunn, and Messerli (1983).
Several studies have examined the effects of acute and chronic 
administration of beta blockers upon CV reactivity in both healthy and 
diseased subjects (e.g., Bonelli, 1982; Erdmann, & Lindern, 1980;
Krantz et al., 1982; Langer et al., 1985; Schmeider et al., 1983;
Smyth, Hughson, Walters, & Ranney, 1984; Weiss, Del Bo, Reichek, & 
Engelman, 1980). Consistently, HR decreases which were generally 
statistically and clinically, e.g., 25 BPM to the stress of mental 
arithmetic (Bonelli, 1982), significant have been demonstrated. Blood 
pressure reductions have also been noted with SBP showing more 
pronounced physiologic, as well as statistically demonstrable, effects 
than DBP. The BP effects, however, may in part be artifact for BP
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effects are associated with long-term treatment rather than short-term 
or acute administration (Frolich et al., 1983). Additional 
considerations in evaluating the effects of beta blockade are the 
individual’s response to beta blockade, i.e., all subjects/patients do 
not show the desired physiologic response, and the potency of the 
particular beta blocker, e.g., timolol has eight times the beta 
blocking potency of propanolol.
Another class of drugs which many of the patients (13 of 45 
patients) were receiving was calcium channel blockers. The main effect 
of calcium channel blockers is a decrease in arterial smooth muscle 
tone which has the cardiovascular effects of decreasing blood pressure 
and raising the threshhold of anginal pain (Luft, Aronoff, Sloan, 
Fineberg, & Weinberger, 1985). The HR effect is variable and dependent 
upon the particular pharmacologic agent (Mitchell, Schroeder, & Mason, 
1982). For a more detailed explanation of the mechanisms of these 
agents, the reader is referred to the two previously cited papers or 
Flaim and Zelis (1981). The HR changes are generally modest and as 
likely to be increases as decreases. Calcium channel agents have not 
been in use for as long a period as beta blockers (10 vs 20 years) and 
their effects have not been fully evaluated. However, investigations 
of the effects of exercise and other primarily physical stressors have 
noted reduced BP reactions with medication (Flaim & Zelis, 1981).
In sum, the pharmacological regimes which patients in the present 
study were receiving likely had a significant impact upon the 
evaluation of Hypothesis 2, i.e., treatment would have a beneficial 
effect upon CV reactivity. Beta blockers were being administered to 
91% of the patients and calcium channel blockers to 29% of the
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patients. Ideally, medication would have been stopped prior to the 
pre- and posttreatment evaluations. However, medication could not be 
stopped due to the patients' cardiac status and even if medication had 
been discontinued another potentially confounding variable might have 
affected the reactivity results.
Concurrent therapy (exercise) considerations. In addition to 
possibly altering the patients Type A behavior (see previous 
discussion), aerobic exercise may have altered their CV reactivity.
The hypothesis that exercise training (or fitness level if already 
trained) can alter reactivity has recently been examined in several 
studies but the evidence is not conclusive. In two recent studies with 
young adults (Lake, Suarez, Schneiderman, & Tocci, 1985; Sinyor, 
Schwartz, Peronnet, Brisson, & Seraganian, 1983), the CV responses of 
trained and untrained subjects were compared. Sinyor et al. reported 
that the trained subjects had a significantly lower HR at baseline and 
throughout recovery but that differences were not significant during 
the application of the stressors. Lake et al. also reported baseline 
differences between their fit and unfit subjects but did demonstrate 
significantly greater SBP and DBP reactivity in the unfit subjects.
The differences in BP reactivity were apparent only during the SI.
Lake et al. speculated that the interpersonal interview may be more 
typical of daily stresses than their other stressors, e.g., a card 
game, cold pressor. Therefore, the greater CV responses of the 
sedentary subjects during the SI may be more pathognomic than the CV 
responses during the unusual stressors.
Using older adults as subjects, Hull, Young and Ziegler (1984) 
reported reduced HR and DBP responses but similar SBP responses in fit
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and unfit subjects. Finally, a training study by Keller and Seraganian
(1984) indicated that the responses of untrained (unfit) subjects 
became similar to the responses of trained (fit) subjects over the 
course of a nine week fitness program. Our group at the University of 
Tennessee (Moes, Alpert, & Murphy, 1985) has also been investigating 
the relationship between fitness and reactivity in adolescents. We 
have found that maximal oxygen consumption (a measure of fitness) as 
determined during a maximal exercise test on a cycle ergometer was 
significantly and inversely related to the maximal HR obtained during 
the stress of a video game. A recent review of exercise as a modulator 
of CV reactivity (Dimsdale, Alpert, & Schneiderman, in press) indicated 
that the evidence is suggestive but that further research is needed to 
more clearly define the relationship between fitness and reactivity.
To summarize the CV reactivity results, participation in the 
stress management program did not ameliorate patients' reactivity to 
either the QE or the cold pressor. The primary hypotheses advanced to 
account for this lack of change are that the patients' medication 
regimens precluded the demonstration of substantial reactivity (and, 
therefore, reactivity reduction) and that their long-standing exercise 
regimen may have induced reactivity reductions prior to the initiation 
of the stress management program. These factors may have exerted their 
effects independently or in concert.
Change in Secondary Variables
Now, turning to the secondary outcome variables utilized in this 
investigation, results of treatment paralleled results for the behavior 
pattern and reactivity. These particular measures, i.e., lipids, 
State-Trait Anxiety Inventory (Spielberger et al., 1970), Locke-Wallace
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Marital Adjustment Scale (Locke & Wallace, 1959), and Holmes-Rahe 
Inventory of Life Events (Holmes & Rahe, 1967) were selected due to 
their usage in previous investigations (see Introduction) or due to the 
interest of the investigator, i.e., marital satisfaction (cf. Murphy et 
al., 1982). First, lipids, particularly cholesterol, have been 
examined in several intervention studies showing beneficial change 
(Adsett & Bruhn, 1964; Friedman et al., 1984; Roskies et al., 1979), 
detrimental change (Jenni & Wollersheim, 1978), and no change (Ibrahim 
et al., 1974; Rahe et al., 1979). However, because initial cholesterol 
levels (see Table 14) were not elevated (generally less than the 50th 
percentile), beneficial cholesterol changes may have occurred prior to 
this investigation, as with other outcome variables in this study.
Thus, cholesterol change.may have been affected by a relative "floor" 
effect in these patients. The LDL decrease which occurred across all 
patients was beneficial as LDL levels are directly related to CHD risk. 
The trade-off was an increase in VLDL concentration. However, the 
VLDL-CHD association is not as strong as the LDL-CHD association. 
Changes in the two lipoprotein fractions were not related to treatment. 
As with changes in the behavior pattern and reactivity, evidence 
suggests that lipid levels may have been affected by the patients' 
exercise training (e.g., Seals, Hagberg, Hurley, Ehsani, & Holloszy,
1984) and their medication (e.g., Weinberger, 1985).
As with the lipid changes, reductions in anxiety have not been 
shown to be consistently associated with Type A interventions. While 
Suinn (1982) suggests that highly anxious subjects benefit the most 
from treatment, this suggestion may also be confounded by regression to 
the mean among the highly anxious subjects. A more recent study (Byrne
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et al., 1985) concluded that anxiety, as a trait or state, formed no 
real part of the TABP. The present study suggests that the Byrne et 
al. conclusion may be accurate. Score changes on the STAI were very 
modest, mean group changes ranged from a decrease of 3.2 points to an 
increase of 2 points, and changes were not affected by patients1 
treatment condition. However, because behavior pattern changes were 
also modest and unaffected by treatment condition, the efficacy of a 
Type A intervention upon anxiety can not be assessed adequately in the 
present study.
In contrast with the small changes exhibited on the STAI, changes 
on the Inventory of Life Events were sometimes very substantial and 
indicated increases in stressful life events. Again, changes from pre- 
to posttreatment were not significantly affected by treatment 
condition. The Holmes-Rahe Inventory has not been used in previous 
studies for these studies, like the present study, were short-term 
studies and there is little reason to believe that many significant 
events would occur over a three to four month period. However, the 
present study was originally conceived to include a follow-up period 
during which important life events could occur. None-the-less, the 
increase in life event scores suggest that the treatment program (and 
assessment procedures in the waiting list conditions) may have had a 
sensitizing effect upon patients perceptions or recollections of life 
events. If patients, in fact, perceived their lives as more stressful 
at the conclusion of the treatment, then the awareness of these 
stressors may have been accompanied by increased coping with these life 
events for, as already noted, the life event changes were not 
accompanied by negative changes in the TABP or CV reactivity. This
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hypothesis is tenuous and would, clearly, need corroberation from 
future research. Another measure which has not been used in previous 
Type A investigations is the Locke-Wallace Scale. This scale was 
selected as an outcome evaluation measure because changes in the TABP 
could hypothetically improve marital adjustment. However, the married 
subjects in the present study were already well-adjusted in their 
marriages as attested to by the group pretreatment means of 111.4, 
109.9, and 112.8 for the behavioral, supportive, and waiting list 
groups, respectively. Locke and Wallace (1959) considered a score of 
100 as the criterion for well-adjusted marriages. Thus, patients may 
have been handicapped by a relative ceiling effect in this study though 
small improvements in the adjustment scores were noted in all three 
groups at posttreatment.
Finally, the weekly stress ratings provide another suggestion, 
albeit a slight suggestion in terms of the overall pattern of results, 
that treatment was beneficial. Differences between the two treatment 
conditions were significant during the seventh and eighth weeks. Also, 
the comparison of the three experimental conditions, which was 
nonsignificant at pretreatment, was significant at posttretment when 
the two treatment 'conditions reported significantly less stressful 
weeks than the no treatment condition. However, the clinical 
significance of a one point change (posttreatment mean minus 
pretreatment mean from Table 15) on an 11 point rating scale would seem 
to be modest at best. Therefore, the changes in weekly stress ratings, 
in combination of the Holmes-Rahe Life Events changes, may be 
considered as tentative evidence of a modest degree of therapeutic 
efficacy. This conclusion is quite tentative for considering the
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number of analyses performed, these findings may be merely artifact, 
i.e., some significant results might be expected on the basis of chance 
alone.
In conclusion, the present study failed to support the hypothesis 
that a stress management program would be effective in altering the 
Type A behavior pattern and cardiovascular reactivity. While these 
results may be due to the characteristics of the stress management 
program, a more cogent explanation involves this particular patient 
sample. The patients who participated in the stress management program 
were older than the patients in previous investigations and were 
receiving concurrent therapy. This concurrent therapy (exercise and 
medication) had been received for a prolonged period of time and 
previous work suggests alterations of the Type A behavior pattern, 
reactivity, psychological well-being, and blood chemistry. An equal, 
if not more important, consideration is that in this patient sample the 
behavior pattern was not related to the severity of CAD. Modest 
evidence suggested that the patients' abilities to cope with stress was 
slightly improved with participation in treatment. Further, the 
demonstration that patients' values on the outcome measures generally 
decreased in all conditions during the treatment period suggests that 
assessment may have had a sensitizing effect upon the patients, i.e., 
through assessment patients may have become more aware of their 
behavior and taken appropriate corrective action. While the cited 
studies support these conclusions and explanations, the explanation of 
why this treatment program was ineffective with this patient sample is 
very speculative and based upon subjective comparisons with previous 
studies. The hypotheses advanced in this discussion can only be
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confirmed by future investigations which prospectively examine these 
potentially mitigating variables. Future research should also seek to 
determine what treatment can help which patients ameliorate the TABP 
and CV reactivity and when the TABP and CV reactivity are pathognomic 
for recurrent coronary events.
Summary
This investigation sought to determine the efficacy of a stress 
management program in the amelioration of the Type A behavior pattern. 
The subjects were 45 patients enrolled in the Cardiac Rehabilitation 
Program of the Veterans Administration Medical Center in Augusta, 
Georgia. Patients were randomly assigned to the experimental 
conditions, i.e., behavioral, supportive, and waiting list, based upon 
exhibition of the Type A behavior pattern. The treatment program 
consisted of 10 sessions of 1-1% hours duration. The outcome of the 
treatment program was based upon an evaluation of changes in a variety 
of behavioral, physiologic, and self-report indices.
The results did not support the two major hypotheses: (a)
patients in the behavioral stress management program would evidence 
superior change in Type A behavior as assessed by the Structured 
Interview, and (b) patients in thr behavior stress management program 
would evidence superior change in cardiovascular reactivity to the 
stress of the cold pressor and the Quiz Electrocardiogram. Though 
changes occurred from pre- to posttreatment, these changes were not 
significantly affected by the treatment condition. Secondary dependent 
measures of anxiety, life events, marital satisfaction, and lipids also 
failed to demonstrate changes which were affected by treatment.
Finally, results provide a suggestion that treatment was effective in 
ameliorating every day stress. Treatment was perceived as beneficial 
by the participants and their spouses and as potentially beneficial by 
members of the cardiac rehabilitation staff.
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The failure of the treatment program to demonstrate beneficial 
change was discussed in terms of four interrelated factors: (a) the
negative association between the behavior pattern and the severity of 
coronary artery disease in this patient sample, (b) the patients' ages, 
(c) the patients' medication regimens, and (d) the patients' prolonged 
participation in an exercise oriented rehabilitation program. In sum, 
patient characteristics and previously established treatment regimens 
may have precluded an adequate examination of the efficacy of a 
short-term intervention program in the amelioration of the Type A 
behavior pattern. Future research should seek to define those 
parameters of subjects and treatment which may independently or 
synergistically affect Type A interventions.
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Appendix 1
STRESS MANAGEMENT IN CARDIAC REHABILITATION
Joseph K. Murphy, M.A.
I have been invited to participate in a research study on stress 
management. This study is designed to study the usefulness of stress 
management in cardiac rehabilitation. I understand that I have been 
asked to participate because I am participating in the Cardiac 
Rehabilitation Program.
I understand that past research suggests that stress management 
programs are helpful for cardiac rehabilitation. However, the research 
does not show what type of program help patients the most. Therefore, 
this research study is going to compare being in two different kinds of 
stress management programs with not being in any stress management 
program. That is, there will be three conditions of participation:
(1) a group focusing on behavior, (2) a group focusing upon emotions, 
and (3) a group that does not receive treatment. I understand that all 
patients will be assigned to the groups at random and I may not be in 
the group that I had initially wanted to be in. I understand that the 
stress management program does not replace the Cardiac Rehabilitation 
Program and that I will continue to receive treatment and participate in 
the Cardiac Rehabilitation Program and that I will continue to receive 
treatment and participate in the Cardiac Rehabilitation Program even if 
I am in the no treatment stress management program.
All Participants
I am being asked to complete several questionnaires concerning 
information about how I handle stress and how it affects my life. I 
will experience no substantial physical discomfort from this procedure.
I am also being asked to donate three (3) ten (10) milliliter blood 
samples. One sample will be collected before the groups begin, one 
after the weekly group meetings end, and the third sample will be 
collected six months after the end of the weekly meetings. Each blood 
sample represents about one (1) tablespoon of blood. This is a part of 
the Cardiac Rehabilitation Program and their program evaluation. That 
is, the same samples will be used by Cardiac Rehabilitation and the 
stress management study. Blood will be drawn in a manner consistent 
with established Cardiac Rehabilitation Procedures. I will also be 
asked to place my hand in a container of ice water to measure my 
response to stress. I understand that I may remove my hand when I want 
to and will be asked to remove it after five (5) minutes. This 
procedure will be performed in a manner consistent with already 
established cardiology procedures. The blood work and ice water stress 
test will possibly involve mild to moderate physical discomfort. A 
final procedure, will be a videotaped structured interview. This
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interview has been used extensively with cardiac patients and will be 
used in the present study in such a manner. While there may be some 
psychological discomfort due to being videotaped, there will be no 
physical discomfort. I understand that I am one of 45-60 patients to 
participate in this study and that my completion of the assessment 
instruments will help determine how useful the stress management program 
is. My total participation in the study will take approximately 30 
hours.
Participants receiving group treatment
I understand that in order to participate in the Stress Management 
Program I must attend at least eight (8) of the ten (10) stress 
management treatment meetings and complete the post-treatment 
assessments. During follow-up, I must attend four (4) of the six 
follow-up meetings and complete the follow-up assessments.
Participants not receiving group treatment
I understand that assignment to conditions will be random and that I 
may not be able to participate in one of the two group treatments. 
However, I will still complete the measurements at pre-treatment, post­
treatment, and follow-up. My completion of the assessment measurements 
will help determine if stress management is helpful for cardiac 
rehabilitation patients and if so, which type of program is more 
helpful. After the six month follow-up I will be offered the treatment 
program shown to be most effective.
I understand that the possible benefits of this study are that data 
may be obtained which will give psychologists, physicians and others 
interested in cardiac rehabilitation a better understanding of possible 
psychological factors that are involved and possible information which 
might aid in treatment. Perhaps more importantly, I may also learn to 
better control my responses to stress.
I understand that this evaluation of my ability to handle stress does 
involve direct psychological treatment procedures. The assessment 
procedures (tests) supply data which is frequently used in the 
psychological assessment of stress as well s in cardiac rehabilitation 
programs.
I understand that my records will become part of the hospital chart 
and that I will not be personally identified in any publication of the 
results of this study.
In case of any adverse effect or physical injury resulting from this 
study, eligible veterans are entitled to medical treatment.
Compensation may be payable under Title 38 U.S.C. 351 or in some 
circumstances under the Federal Tort Claims Act. Non-eligible veterans 
or non-veterans are entitled to medical care and treatment on 
humanitarian emergency basis. Compensation would be limited to
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situations involving negligence and would be controlled by the 
provisions of the Federal Tort Claims Act.
I understand that Joseph K. Murphy, M.A., who can be reached at 
extension 2869, will answer any and all questions that X may have at any 
time concerning the study, the procedures, and any injuries that may 
appear to be related to the research. If I have any questions or 
concerns about the rights of research subjects, I may contact Dr. Thomas 
A. Huff at 828-2131.
My participation in this study is voluntary. I understand, however, 
that I may revoke my consent and withdraw from the study now or at any 
time in the future, without penalty or loss of care or other benefits to 
which I am otherwise entitled.
I voluntarily consent to participate in this study.
SUBJECT'S SIGNATURE DATE
(* or legal guardian or patient's 
representative)
INVESTIGATOR'S SIGNATURE WITNESS' SIGNATURE
* The undersigned hereby verified that he/she is the Legal Guardian or
Parent's Representative of _____________________________  and as such as
legal authority to consent to the study outlined above.
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Appendix 2
Medical College of Georgia 
Augusta, Georgia 30912
Division of Research Administration
February 22, 1983
Joseph K. Murphy, M.A. 
Department of Psychology 
116-B
VA Hospital 
Augusta, Georgia 30910
RE: Project Title - "Stress Management In Cardiac Re­
habilitation"
Approval Date - February 22, 1983
Dear Dr. Murphy:
The Human Assurance Committee has reviewed and approved the 
addendum submitted January 12, 1983 to the above referenced 
project "Stress Management In Cardiac Rehabilitation" in ac­
cordance with the DHHS policy and the institutional assurance 
on file with the DHHS.
Sincerely,
Thomas A. Huff, M.D. 
Chairman
HUMAN ASSURANCE COMMITTEE
TAH/jb
Appendix 3
V eterans
A dm in istra tion
Oats: March 8, 1983
To: Joseph K. Murphy, M.A.
M em orandum
From: chairman, R&D Committee
Subi: "Stress Management in Cardiac Re­
habilitation"
The Research and Development Conmittee concurred with the recommendation of the 
Human Assurance Committee and approved the above referenced protocol for 
use at the Veterans Administration Medical Center in their meeting held on 
February 22, 1983.
JOHN.P. BOINEAU, M.D.
A p p e n d i x  4
Treatment Credibility Questionnaire
Strongly Moderately Moderately Strongly
Yes Yes Unsure No No
Do you consider this Type A/stress 
management program to be a logical 
and reasonable approach to altering 
Type A behavior and/or stress 
management?
Do you feel that the program that 
you received was successful for you?
Do you feel that the Type A/stress 
management procedures used in your 
group would work for most other 
people with problems similar to yours?
Are you confident that you will be 
able to at least maintain the 
improvements made in treatment?
Would you recommend this program 
for your friends who would like 
to alter their Type A behavior 
or their response to stress?
Note: Questions were scored on a scale from 1 (strongly no) to 5 (strongly yes) and
summed to obtain a total score. For the Rehabilitation Program staff, questions 
2 - 4  were reworded to refer to cardiac patients in general.
1 4 0
A p p e n d i x  5
NAME _____________________________  DATE__________________________
Below are listed a variety of events that may be viewed as stressful 
or unpleasant. In the space next to each item indicate if the event 
occurred this week and, if so, the degree of subjective stress that you 
experienced. Also, in the spaces provided at the end, list any addi­
tional unpleasant events that you experienced and the degree of sub­
jective stress associated with each event. Please answer the following 
items as honestly as you can so that we can obtain accurate data.
X = did not occur 2 = a little stress 5 = very much stress
0 = not stressful 3 = some stress 6 = panic
1 = very little stress 4 = much stress
1. Late for work/appointment
2. Poor performance at task
3. Poor performance due to 
others
4. Thinking about unfinished 
work
5. Hurrying to meet deadline
6. Interrupted during task/ 
activity
7. Someone spoils your 
completed task
8. Doing something you are 
unskilled at
9. Someone you supervise 
performs poorly
10. Unable to complete a task
11. Being unorganized
12. Criticized or verbally 
attacked
13. Ignored by others
14. Speaking or performing in 
public
15. Dealing with rude waiter/ 
salesperson
16. Interrupted while talking
17. Meeting a new person
18. Unexpected visitors
19. Being forced to socialize
20. Someone breaks a promise/ 
appointment
21. Unsolicited salesperson/ 
charity
22. Competing with someone
23. Being stared at
24. Not hearing from someone 
you expected to hear from
25. Experiencing unwanted 
physical contact 
crowded, pushed)
26. Being misunderstood
27. Being embarrassed
28. Malfunction of machinery 
or appliance
29. Running out of food/ 
personal articles
30. Problems with utilities/ 
postal service
31. Arguing with spouse/ 
boyfriend/girlfriend
32. Arguing with another 
person
33. Problems with kid(s)
34. Dealing with parents
35. Waiting longer than 
you wanted
36. Interrupted while 
thinking/relaxing
37. Someone cuts ahead of 
you in a line
38. Poor performance at 
sports/games
39. Doing something you 
don't want to do
40. Inability to complete 
all plans for today
41. Car trouble
42. Difficulty parking car
43. Difficulty in traffic
44. Auto accident
45. Money problems
46. Being overcharged for 
a purchase
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X = did not occur
0 = not stressful
1 = very little stress
2 = a little stress
3 = some stress
4 = much stress
5 = very much stress
6 = panic
47. Store lacks a desired item
48. Problem with vending 
machine
49. Misplacing something
50. Worrying about other 
people's problems
51. Bad weather
52. Unexpected expenses (i.e., 
fines, traffic tickets)
53. Having your sleep disturbed
54. Forgetting something
55. Fear of illness/pregnancy
56. Experiencing illness/ 
physical discomfort
57. Someone borrows something 
without permission
58. Your property is damaged/ 
destroyed
59. Minor accidents (break 
something, tear clothing)
60. Thinking of the future
71. _____
72. _____
73. _____
74. _____
75.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
Hearing bad news 
Concern over personal 
appearance 
Confrontation with 
authority figure 
Visiting a doctor/ 
dentist 
Dieting
Exposure to fear 
situations or objects 
Exposure to upsetting 
TV show, movie, book 
"Pet Peeves" violated 
(i.e., someone fails 
to knock)
Failing to understand 
something
Experiencing a narrow 
escape from danger
OVERALL WEEKLY STRESS RATING
Please circle the number that corresponds to your overall level of 
stress this week. Ratings should reflect your own subjective feelings 
of discomfort (i.e., the degree to which you feel pressured, worried, 
hassled).
0 1 2 3 4 5 6 7 8 ■ 9 10
No Comfortable Uncomfortable Very Stress
Stress Uncomfortable Equal to
the most 
stressful 
week I 
have had
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